DEPT OF OBSTETRICS & GYNAECOLOGY

Researcher : Chan CCW



List of Research Outputs

 

Ng E.H.Y., Chan C.C.W., Tang F.O.S. and Ho P.C., Comparison of 2-Dimensional, 3-Dimensional, and vascular ultrasonographic parameters for endometrial receptivity between 2 consecutive stimulated in vitro fertilization cycles, Journal of Ultrasound In Medicine. 2007, 26(7): 931-939.

 

Ng E.H.Y., Chan C.C.W., Tang F.O.S., Yeung W.S.B. and Ho P.C., The role of endometrial blood flow measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment, European Journal of Obstetrics and Gynecology and Reproductive Biology. 2007, 135: 8-16.

 

Tang G.W.K., Leung K.Y. and Chan C.C.W., Use of hormone therapy: POST-WHI ERA in Hong Kong, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, Tokyo, Japan September 21-25 . 2007.

 

Researcher : Chan CP



List of Research Outputs

 

Chan C.P. and Lao T.T.H., Effect of parity and advanced maternal age on obstetric outcome, International Journal of Gynecology and Obstetrics. Elsevier Ireland Limited, 2008, 102: 237-241.

 

Chan K.W., Chan G.S.W., Tse K.C. and Chan C.P., Genotypic and phenotypic divergence: lessons from a family of Fabry’s disease, 24th World Congress of Pathology and Laboratory Medicine, 20-24 August 2007, Kuala Lumpur, Malaysia. 2007.

 

Hui P.W., Leung W.C., Au W.Y., Chan C.P. and Lao T.T.H., A rare cause of thrombocytopenia in pregnancy – EDTA-dependent pseudothrombocytopenia, 31st British International Congress of Obstetrics and Gynaecology, 3 – 6 July 2007, London, United Kingdom. 2007.

 

Lao T.T.H., Chan C.P., Leung W.C., Ho L.F. and Tse K.Y., Maternal hepatitis B infection and gestational diabetes mellitus, Journal of Hepatology. 2007, 47(1): 46-50.

 

Researcher : Chan DW



Project Title:

Characterization of the roles of Dual specificity MAPK phosphatase 3 (MKP-3) in ovarian cancer

Investigator(s):

Chan DW, Ngan HYS

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2006

 

Abstract:

Ovarian cancer is one of the leading causes of death in women. Although there have been advances in the treatment of ovarian cancer, the associated mortality rate of this cancer has not improved significantly over the past decade. Therefore, understanding the molecular mechanisms in the development of ovarian cancer through identification and characterization of oncogenes and tumor suppressor genes will help discovery of novel targets for therapies. To achieve this, we have previously done cDNA microarray analysis on ovarian cancer cell lines and immortalized human normal surface epithelial cell lines (HOSEs). We found that a gene called Dual specificity MAPK phophatase 3 (MKP-3/DUSP6) was downregulated in ovarian cancer cells. Many studies have documented that MKP-3 possesses anti-tumorigenic effect on pancreatic cancer through inactivation of ERK activity (Furukawa et al., 1998; Furukawa et al., 2003). The finding of underexpression of MKP-3 in ovarian cancer cells indicates that this gene may play a role in the development of ovarian cancer. The objectives of this research proposal are: 1. To evaluate the expression status of MKP-3 in ovarian cancer cell lines, HOSEs, and clinical samples. Clinicopathological correlation will be analyzed with the expression status of MKP-3 in patients’ samples. 2. To investigate the relationship between MKP-3 expression status and ERK1/2 activity in ovarian cancer cell lines and clinical samples. 3. To evaluate the change of tumorigenicity of ovarian cancer cells by stably transfected with MKP-3 expressing constructs and/or knock-down MKP-3 by RNAi technique. 4. To delineate the signalling pathways in MKP-3/ERK/downstream targets regulation in ovarian cancer cells.

 

List of Research Outputs

 

Chan D.W., Lee Y.W., Liu V.W.S. and Ngan H.Y.S., Overexpression of AMPKgamma 2 enhances tumorigenicity of Ovarian Cancer Cells, Annual Meetings of American Association for Cancer Research, April 12-16, 2008, San Diego, CA, USA. 2008.

 

Liu V.W.S., Chan D.W., To M.Y., Chiu C.N. and Ngan H.Y.S., Forkhead box transcription factor FoxG1 is over-expressed in ovarian cancer and can inhibit p21 expression, Annual Meeting of the American Association for Cancer Research, April 12-16, 2008, San Diego, U.S.A.. 2008.

 

Yip C.T., Chan D.W., Liu V.W.S. and Ngan H.Y.S., Zic2 synergistically enhances Hedgehog signaling pathway in cervical cancer., The 12th Research Postgraduate Symposium 2007, The University of Hong Kong, Hong Kong, 12 Dec. 2007.. 2007.

 

Yip C.T., Chan D.W., Liu V.W.S. and Ngan H.Y.S., Zic2 synergistically enhances Hedgehog signaling pathway in cervical cancer., The 99th Annual Meeting of American Association of Cancer Research, 12-16 April 2008, San Diego, CA, USA.. 2008.

 

Researcher : Chan KKL



Project Title:

Relationship between placental ratio and placental function

Investigator(s):

Chan KKL, Lao TTH

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Seed Funding for New Staff

Start Date:

01/2003

 

Abstract:

To examine the relationship between PR and placental function in terms of fetal acid- base balance, haematology and biochemiatry; to determine if there is a cut-off in the PR for the detection of fetal growth restriction (FRG) as reflected by changes in placental function in newborns with birthweigth within the normal range.

 

Project Title:

The role resistin in gestational diabetes and its relationship with pregnancy outcome

Investigator(s):

Chan KKL, Lam KSL, Lao TTH

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Seed Funding Programme for Basic Research

Start Date:

02/2004

 

Abstract:

To investigate the hypothesis that resistin expression is associated with insulin resistance in pregnancy and has implications on neonatal outcome.

 

Project Title:

Iron supplement in pregnancy and development of gestational diabetes - a randomized placebo-controlled trial

Investigator(s):

Chan KKL, Lao TTH

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Competitive Earmarked Research Grants (CERG)

Start Date:

01/2005

 

Abstract:

To conduct a randomized placebo control trial to establish the relationship between iron store and development of GDM; to explore the mechanism by which a high iron load is related to GDM; to explore the relationship between iron store and liver production of insulin resistance; to explore the relationship between iron store and liver production of IGF which has similar action as insulin on glucose metabolism, whose level has been associated with development of disbetes.

 

Project Title:

Oestrogen receptor subtypes status in ovarian cancer

Investigator(s):

Chan KKL, Tam KF, Ngan HYS, Chan YK, Liu B

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

01/2006

 

Abstract:

Objective : To investigate the relationship between oestrogen receptors subtypes and clinical parameters in ovarian cancer Key issues and problem addressed: Ovarian cancer cells, like breast cancer cells, express oestrogen receptors (Rao 1991) and are oestrogen sensitive. Oestrogen is a steroid hormone, mainly synthesised in the ovary but also in peripheral tissues through aromatization of androgen (Korach KS 1996). It has diverse effects the reproductive system as well as other tissues such as the cardiovascular system and bone tissues. On the molecular level, oestrogen regulates the expression of many genes that are important for cell proliferation, inhibition of apoptosis, stimulation of invasion and metastasis and promotion of angiogenesis. Most of the effects of oestrogen are medicated by oestrogen receptors (ER). ER has at least 2 functions. Apart from being a transcription factor for oestrogen related genes, it also functions outside the nucleus and in the plasma membrane to active growth factor signalling ( Osborne CK 2005 ). Therefore, it can potentially affect tumour growth and clinical outcomes in ovarian cancer. The role of oestrogen receptors had been investigated in ovarian cancer. A number of earlier studies in the eighties and early nineties attempted to look at the relationship between presence of ER and survival but did not produce any firm conclusions ( Massood S 1989, Anderl P 1988, Rose P 1990, Geisler J, 1995 ). This may be due to the heterogeneous data set and the dextran coated charcoal adsorption assay used to detect ER which is now largely replaced by the more accurate immunohistochemical (IHC) method. Furthermore, In addition to the classical oestrogen receptor ( ER-a ), a second ER, ER- β was identified in 1996 (Mosselman S 1996 ). These both belong to a super family of nuclear hormone receptors but they are products of different genes. They have similar but not identical structures and they appear to have distinct functions from each other for example, ER- β seems to have opposing activity on tumour growth. These earlier studies did not differentiate between the presences of the receptor subtypes which may have an impact on the overall findings, particularly when the 2 subtypes appear to have opposing actions. Subsequent studies have attempted to look at the role of ER- β in ovarian cells. Hillier et al ( Hillier SG 1998 ) screened for ER-A and ER – β mRNA in primary benign ovarian epithelial cell cultures by RT-PCR in 4 women, using granulosa cells and granulosa –lutein cells as controls and found that these cells expresses mRNA for both subtypes. Brandenberger (Brandenberger 1998) measured the mRNA of ER- β expression in 10 normal ovaries and 10 serous cystadenocarcinoma as well as in normal and malignant ovarian cell lines. He found that ER- β was decreased in both ovarian cancer tissue and cell lines compared to normal. Li et al (Li 2003 ) compared ER a and β mRNA in primary cell cultures of normal ovarian epithelium ( n=23 ) verses in ovarian cancer ( n= 23 ) and found that Ratio of ER a / ER βwas 10 times higher in Ca ovary. Bardin et al (Bardin 2004) showed in 58 women that ER- β expression was were reduced during tumour progression and they restored ER- β expression in ovarian cancer cell line and found that ER-B expression strongly inhibit cell proliferation. Lindgren et al (2004) also looked at ER subtypes expression in ovarian tumours by using immunostaining rather then by measuring mRNA expression by RT-PCR and confirmed that ER-B immunuoreactivity was lower in epithelial cells in ovarian cancer than in normal ovaries. From these studies, it appears that the level of ER- β expression would be an important factor in ovarian carcinogenesis and may have implications on response to treatment and clinical outcomes. Therefore in this study, we would like to correlate the ER a and β status with clinical parameters and to attempt to answer the following questions: How does receptor subtype status correlate • with different histological types of ovarian cancer • with response to chemotherapy • with progression free interval References Anderl P. Fuith LC. Daxenbichler G. Marth C. Dapunt O. Correlation between steroid hormone receptors, histological and clinical parameters in ovarian carcinoma. Gynecologic & Obstetric Investigation. 25(2):135-40, 1988. Bardin A. Hoffmann P. Boulle N. Katsaros D. Vignon F. Pujol P. Lazennec G. Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Research. 64(16):5861-9, 2004 Aug 15. Brandenberger AW. Tee MK. Jaffe RB. Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. Journal of Clinical Endocrinology & Metabolism. 83(3):1025-8, 1998 Mar Hillier SG. Anderson RA. Williams AR. Tetsuka M. Expression of oestrogen receptor alpha and beta in cultured human ovarian surface epithelial cells. [Journal Article] Molecular Human Reproduction. 4(8):811-5, 1998 Aug. Korach KS, Migiaccio S, Davis VL. Estrogen. In: Munson PL, eds Principles of Pharmacology. New York: Chapman & Hall, 1996; 809-25 Li AJ. Baldwin RL. Karlan BY. Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures. American Journal of Obstetrics & Gynecology. 189(1):22-7, 2003 Jul Masood S, Heitmann J, Nuss R, Bernrubi G. Clinical correlation of hormone receptor status in epithelial ovarian cancer. Gynecol Oncol 1989; 34: 57-60 Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett, 392: 49-53, 1996. Osborne CK. Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. Journal of Clinical Oncology. 23(8):1616-22, 2005 Mar 10. Perez-Gracia JL. Carrasco EM. Tamoxifen therapy for ovarian cancer in the adjuvant and advanced settings: systematic review of the literature and implications for future research Gynecologic Oncology. 84(2):201-9, 2002 Feb. Rao BR, Slotman BJ. Endocrine factors in common epithelial ovarian cancer. Endocr Rev, 12: 14-26, 1991

 

Project Title:

To investigate the relationship between oestrogen receptor subtype status and the effects of oestrogen agonists, antagonists and selective oestrogen receptor modulators ( SERM) on ovarian tumour cell growth

Investigator(s):

Chan KKL, Tam KF, Ngan HYS

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

01/2007

 

Abstract:

Oestrogen regulates the expression of many genes that are important for cell proliferation, inhibition of apoptosis, stimulation of invasion and metastasis and promotion of angiogenesis. Most of the effects of oestrogen are medicated by oestrogen receptors (ER). ER has at least 2 functions. Apart from being a transcription factor for oestrogen related genes, it also functions outside the nucleus and in the plasma membrane to active growth factor signalling. Ovarian cancer cells express oestrogen receptors and are oestrogen sensitive. Therefore, oestrogen can potentially affect ovarian cancer cell growth. Hormonal therapy is an attractive option in the treatment of ovarian cancer because of its better side effect profile compared to standard chemotherapy regimes. Tamoxifen, a partial oestrogen agonist which is widely used in the treatment of breast cancer has also been used in the treatment of ovarian cancer. However, overall response rate is only about 13% (Perez-Gracia JL et al). Most of the studies on the use of tamoxifen in ovarian cancer did not fully investigate the response with respect to the receptor status of their subjects. Furthermore, a new oestrogen receptor, the ER-β, was discovered after most of these earlier studies and a number of new selective oestrogen receptors modulators and pure antagonists have been developed. Second and third generation SERMs such as raloxifene and arzoxifene had been developed to produce favourable oestrogen activities , for example, prevention of osteoporosis ,while minimizing the less desirable effects such as increasing breast cancer risk. Fulvestrant , a pure oestrogen antagonist, was developed and already licensed for use in treatment for advanced breast cancer. Again, the use of these newer agents in ovarian cancer is much less investigated. While a no. of studies have looked at the effects of oestrogen and tamoxifen on the ovarian cancer cell growth in vitro and suggested that oestrogen might stimulate cell proliferation while tamoxifen might inhibit cell growth (Langdon , Lindgren , Taube ), there is minimal information on the effect of the newer agents. Moreover, the role of oestrogen receptors on these observed effects of oestrogen or tamoxifen on ovarian cancer cell growth was not clear. Although the antiproliferative effect of tamoxifen observed was related to the cytosolic ER content in 18 ovarian tumours (Lazo), no significant differences in ER expression was found between the higher and lower survival groups when cells were cultured in 17 β- oestradiol (Taube ). These previous studies had not taken into account of the receptor subtypes status. In the presence of different receptor subtypes, both oestrogen and tamoxifen may have different actions. In the presence of ER α, both oestradiol and tamoxifen have agonist action, but in the presence of ER β, oestrogen blocks the agonist effect of tamoxifen and tamoxifen would give be a pure antagonistic action ( Barkhem, Hall, Paech, Katzenellenbogen). The differences in action in the presence of different receptor subtypes may lead to the discrepancies observed in previous reports. We therefore propose to study the effects of oestradiol ( the agonist ), different SERMS as well as the pure antagonist on ovarian cell lines with respect to receptors subtypes status. References Perez-Gracia JL. Carrasco EM. Tamoxifen therapy for ovarian cancer in the adjuvant and advanced settings: systematic review of the literature and implications for future research. Gynecol Oncol. 2002; 84:201-9 Langdon SP. Hawkes MM. Lawrie SS et al. Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br J Cancer. 1990; 62:213-6 Lindgren P. Backstrom T. Mahlck CG. et al. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors. Int J Oncol 2001 ;19:31-8 Taube M. Hockenstrom T. Isaksson M. et al Effects of sex steroids on survival and receptor expression in ovarian epithelial tumour cells. Int J Oncol. 2003 ;22:1257-62 Lazo JS. Schwartz PE. MacLusky NJ. et al. Antiproliferative actions of tamoxifen to human ovarian carcinomas in vitro. Cancer Research. 1984 ;44:2265-71 Barkhem T B, Carlsson Y, Nilssson E et al. Differential response of estrogen receptor a and estrogen receptor b to partial estrogen agonists/antagonists. Mol Pharmacol 1998; 54: 105-112 Hall JM, MacDonnell. The estrogen receptor beta-isoform of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999 140:5566-5578 Paech K, Webb P, Kupier G et al. Differential ligand activation of estrogen receptors ER α and ER β at AP-1 sites. Science 1997; 277:1508-1510 Katzenellenbogen BS, Frasor J. Therapeutic targeting in the estrogen receptor targeting pathway. Semin Oncol 2004; 31:28-38

 

List of Research Outputs

 

Chan K.K.L., Ip P.P.C., Kwong P.W.K., Tam K.F. and Ngan H.Y.S., A combination of chemoirradiation and chemotherapy for treatment of advanced clear cell adenocarcinoma of the cervix (p 559-563) , In: John J. Kavanagh and Uziel Beller, International Journal of Gynecological Cancer. Wiley interscience, 2008, 18: 559-563.

 

Chan K.K.L. and Naik R., Advances on surgical treatment of cervical cancer, Women's Health. Future Medicine, 2008, 4: 245-256.

 

Chan K.K.L., Wei N., Liu S., Liao X., Cheung A.N.Y. and Ngan H.Y.S., Estrogen receptor subtypes in ovarian cancer: a clinical correlation, Obstet Gynecol. 2008, 111: 144-151.

 

Chan K.K.L., Management strategies in keeping with the changing faces of gestational trophoblastic neoplasia in SE Asia, The XXth Asian and Oceanic Congress of Obsterics and Gynaecology. . 2007.

 

Chan K.K.L., Tam K.F., Tse K.Y. and Ngan H.Y.S., The role of physical examination in the routine follow up of patients treated for ovarian carcinoma, British Gynaecological Society Annual Conference 2007.

 

Chan K.K.L., Tam K.F., Tse K.Y. and Ngan H.Y.S., The use of vaginal antimicrobial after large loop excision of transformation zone: a prospective randomised trial, British Journal of Obstetrics and Gynaecology. 2007, 114(8): 970-976.

 

Kwan T.T.C., Chan K.K.L., Yip M.W., Tam K.F., Cheung A.N.Y., Young P.M.C., Lee P.W.H. and Ngan H.Y.S., Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative–quantitative study, Sex Transm Infect. 2008, 84(3): 227-232.

 

Leung C.Y., Liu S., Chan Y.K., Tam K.F., Chan K.K.L., Wong R.L.C. and Ngan H.Y.S., Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer, Oncology Reports. 2008, 19: 1339-1345.

 

Liu S., Tsang P.C.K., Chan Y.K., Cheung A.N.Y., Chan K.K.L., Leung C.Y. and Ngan H.Y.S., Distribution of Six Oncogenic Types of Human Papillomavirus and Type 16 Integration Analysis in Chinese Women with Cervical Precancerous Lesions and Carcinomas, Tumour Biol. 2008, 29(2): 105-113.

 

Ngan H.Y.S., Tsang P.C.K., Chan Y.K., Liu S., Cheung A.N.Y., Chan K.K.L. and Leung C.Y., Human papillomavirus genotyping and integration in cervical cancers and precursor lesions, 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November. 2007.

 

Ngan H.Y.S., Kwan T.T.C., Tam K.F., Chan K.K.L., Young P.M., Lo S.S., Cheung A.N.Y. and Lee P.W.H., Knowledge and attitute of Chinese women on cervical cancer and human papillomavirus, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, September 21-25, 2007, Tokyo, Japan. 2007.

 

Tse K.Y., Chan K.K.L., Tam K.F. and Ngan H.Y.S., Current concepts in the management of endometrial carcinoma, Journal of Paediatrics, Obstetrics and Gynaecology. 2007, SEP/OCT: 213-220.

 

Researcher : Chan RWS



List of Research Outputs

 

Chan R.W.S., Role of Estrogen On Mouse Endometrial Epithelial Progenitor Proliferation, International Society of Stem Cell Research 2007.

 

Gargett C.E., Chan R.W.S. and Schwab K.E., Endometrial stem cells., Current Opinion In Obstetrics and Gynecology. England, Lippincott Williams & Wilkins, 2007, 19: 377-383.

 

Gargett C.E., Chan R.W.S. and Schwab K.E., Hormone and growth factor signaling in endometrial renewal: Role of stem/progenitor cells., Molecular and cellular endocrinology. Ireland, North Holland Publishing, 2008, 288: 22-29.

 

Researcher : Chan YK



Project Title:

The signaling pathways of L-SIGN in response to ligand binding

Investigator(s):

Chan YK, Khoo US, Peiris JSM

Department:

Pathology

Source(s) of Funding:

Seed Funding Programme for Basic Research

Start Date:

03/2007

 

Abstract:

L-SIGN (liver/lymph node-specific ICAM-3 grabbing non-integrin) serves as a receptor for many of viral pathogens, including HIV1;2, HCV3, Ebola virus4, and SARS coronavirus (SARS-CoV)5. Its homologue, DC-SIGN, also serves as a receptor for many of the same viruses and has been utilized by some of the pathogens to escape immuno-surveillance. The binding sites of L-SIGN and DC-SIGN appear evolved to serve different functions. DC-SIGN mediates trafficking as a recycling receptor, releasing ligand at endosomal pH. In contrast, L-SIGN does not release ligands at endosomal pH nor does it mediate endocytosis, which indicates that it only functions as a binding receptor6. L-SIGN on transfected cells has been shown to internalize HCV virus-like particles and traffic to either lysosomal or non-lysosomal compartment depending on the cell type7. We speculate that L-SIGN may have other un-explored functions and signaling events after L-SIGN engagement with its ligand. Mitogen-activated protein kinases (MAPKs) are signal transducers that respond to extracellular stimulations, such as cytokines and viral infection. They in turn regulate cell differentiation, proliferation, survival and apoptosis8-11. There are three distinct MAPK cascades, extracellular signal-regulated kinases (ERK1/2), c-JUN N-terminal kinases (JNK), and p38/MAPK. Phosphatidylinositol 3-kinase (PI3K) signaling pathway also plays an important role in various cellular processes including cell growth and survival, vesicular trafficking, etc12. One of the key signaling molecules in the pathway is AKT which phosphorylates targets including GSK-3, FKHR-L1 and BAD. SARS-CoV infected permissive Vero E6 cells (which express the SARS-CoV receptor, ACE213) has been demonstrated to activate the MAPK and PI3K/Atk signaling pathways14-16. p38/MAPK has been shown to be activated during SARS-CoV viral replication14 in the infected cells, decreasing anti-apoptotic activity15. JNK and PI3K/Akt have been found to be important for the establishment of persistence in Vero E6 cells17. All these suggest that signaling pathways of MAPK and PI3K play important roles in regulating cellular responses to viral infection. To date, studies on DC-SIGN signaling are very limited while L-SIGN-mediated signaling has not been documented. Within the cytoplasmic domain of L-SIGN, it shares with DC-SIGN the potential internalization motifs, such as the di-leucine motif, etc.18. In DC-SIGN, the di-leucine motif is essential for receptor internalization19 and it is believed that L-SIGN also shares the same characteristics. A recent study has shown that DC-SIGN engagement on monocyte derived dendritic cells leads to phosphorylation of AKT and ERK20. DC-SIGN ligation has been shown to result in the activation of PI3K and MAPK signaling pathways20. It is possible that L-SIGN may also be involved in similar pathways; hence we will investigate if the presence of L-SIGN may modify MAPK and PI3K signaling activated by viral infection. The extra-cellular neck domain of L-SIGN is encoded by tandem repeats (from 3 to 9 repeats), 7 being predominant in the population. This neck region repeat is important for oligomerization of L-SIGN on the cell surface, which brings the carbohydrate recognition domain which it supports into proximity for high-affinity binding. We have shown that L-SIGN is a binding receptor for SARS-CoV and that heterozygotes in which the tandem-neck repeat lengths differ, have reduced binding for SARS-CoV when compared with homozygotes. Carriers with homozygous repeats were associated with a reduced risk for SARS infection.5 This is supported by our in-vitro observations that homozygous, but not heterozygous L-SIGN, possesses a protective role in reducing the final total viral titer in cultures with permissive cells. In part this may be attributed to a higher binding capacity of homozygous L-SIGN with greater cell association of virons, increased proteasome-dependent viral degradation and consequently a lower capacity for trans infection. This leads us to ask whether hetero- or homo-dimerization of L-SIGN binding with the ligands affects MAPK and PI3K signaling pathways. Objective 1: To investigate whether L-SIGN SARS-CoV binding affects MAPK and PI3K signaling pathways Objective 2: To investigate whether differences in hetero- and homo-dimerization of L-SIGN SARS-CoV binding affect and MAPK and PI3K signaling pathways Reference List 1. Pohlmann S, Soilleux EJ, Baribaud F et al. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc.Natl.Acad.Sci.U.S.A 2001;98:2670-2675. 2. Bashirova AA, Geijtenbeek TB, van Duijnhoven GC et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J.Exp.Med. 2001;193:671-678. 3. Pohlmann S, Zhang J, Baribaud F et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J.Virol. 2003;77:4070-4080. 4. Alvarez CP, Lasala F, Carrillo J et al. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J.Virol. 2002;76:6841-6844. 5. Chan VS, Chan KY, Chen Y et al. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat.Genet. 2006;38:38-46. 6. Guo Y, Feinberg H, Conroy E et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat.Struct.Mol.Biol. 2004;11:591-598. 7. Ludwig IS, Lekkerkerker AN, Depla E et al. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J.Virol. 2004;78:8322-8332. 8. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37-40. 9. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81:807-869. 10. Garrington TP, Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr.Opin.Cell Biol. 1999;11:211-218. 11. Whitmarsh AJ, Davis RJ. A central control for cell growth. Nature 2000;403:255-256. 12. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-1657. 13. Li W, Moore MJ, Vasilieva N et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450-454. 14. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirs-infected cells. Biochem.Biophys.Res.Commun. 2004;319:1228-1234. 15. Mizutani T, Fukushi S, Murakami M et al. Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells. FEBS Lett. 2004;577:187-192. 16. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells. Virology 2004;327:169-174. 17. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. Biochim.Biophys.Acta 2005;1741:4-10. 18. Koppel EA, van Gisbergen KP, Geijtenbeek TB, van KY. Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation. Cell Microbiol. 2005;7:157-165. 19. Sol-Foulon N, Moris A, Nobile C et al. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity. 2002;16:145-155. 20. Caparros E, Munoz P, Sierra-Filardi E et al. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 2006;107:3950-3958.

 

List of Research Outputs

 

Leung C.Y., Liu S., Chan Y.K., Tam K.F., Chan K.K.L., Wong R.L.C. and Ngan H.Y.S., Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer, Oncology Reports. 2008, 19: 1339-1345.

 

Researcher : Chan YL



List of Research Outputs

 

Lee C.Y.L., Chan Y.L., Chow W.N., Ng E.H.Y., Lee C.K.F., Yeung W.S.B. and Ho P.C., Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway., Fertility and Sterility. 2008.

 

Researcher : Chan YM



List of Research Outputs

 

Lee A.H.K., Fong D.Y.T. and Chan Y.M., Psychometric Evaluation of the Hong Kong Chinese Version of Functional Living Index - Cancer in Hong Kong, Asian Chinese Quality of Life Conference. 2008.

 

Researcher : Cheong AWY



List of Research Outputs

 

Cheong A.W.Y., Lee C.Y.L., Liu W., Yeung W.S.B. and Lee C.K.F., Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Cheong KB



List of Research Outputs

 

Leung K.Y., Cheong K.B., Tang M.H.Y. and Chan V.N.Y., Prenatal diagnosis of thalassemia, Journal of Paediatrics, Obstetrics & Gynaecology. 2008, 34: 37-42.

 

Researcher : Cheong WYA



List of Research Outputs

 

Cheong W.Y.A., Lee C.Y.L., Liu Y., Yeung W.S.B. and Lee C.K.F., Best poster presentation award HKSEMR 2007- Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production. , The Annual Scientific Meeting of the Hong Kong Society of Endocrinology, Metabolism and Reproduction, 11 November 2007, Hong Kong.. 2007.

 

Researcher : Cheung TM



List of Research Outputs

 

Ng E.H.Y., Lau E.Y.L., Yeung W.S.B., Cheung T.M., Tang F.O.S. and Ho P.C., Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage, Fertility and Sterility. 2008, 89(5): 1147-1153.

 

Researcher : Chiu CN



Project Title:

Prevalence of Y-chromosome AZFd microdeletion in Hong Kong men with male infertility

Investigator(s):

Chiu CN, Ng EHY, Lee CKF, Yeung WSB

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2004

 

Abstract:

To determine the prevalence of AZFd deletion in a Chinese population in Hong Kong, particularly in a group of men with abnormal sperm morphology. Abnormal sperm morphology is one of the proposed characteristics of men having AZFd deletion.

 

List of Research Outputs

 

Chiu C.N., Wong S.T., Lee C.L., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Native human zona pellucida glycoproteins: purification and binding properties, Human Reproduction. 2008, 23: 1385.

 

Chiu C.N., Wong B.S., Lee C.L., Chung M.K., Lam K.K., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Purification of native human zona pellucida glycoproteins from eggs: Binding characteristics to human spermatozoa, hyper-activation, acrosomal exocytosis, and sperm-oocyte interaction. P.74, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Lee C.K.F. and Yeung W.S.B., Cumulus ooporous-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. O.2.05, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Purification and identification of a glycodelin-C interacting protein from human cumulus matrix, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K., Lee C.L., Pang R., Lee C.K.F. and Yeung W.S.B., Study of the interaction of cumulus-associated alpha-2-macroglobulin with glycodelin-C from human cumulus matrix. P. 196, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., Differential glycosylation regulates the immunosuppressive activities of glycodelins. P3.11, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Lee C.L., Chiu C.N., Chung M.K., Lam K.K., Chu I.K., Lee C.K.F., Lao T.T.H. and Yeung W.S.B., Impaired immunosuppressive activities of glycodelin-A in pregnant women with gestational diabetes mellitus. P.611, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., The immunosuppressive effect of glycodelin-A from amniotic fluid, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Liu V.W.S., Chan D.W., To M.Y., Chiu C.N. and Ngan H.Y.S., Forkhead box transcription factor FoxG1 is over-expressed in ovarian cancer and can inhibit p21 expression, Annual Meeting of the American Association for Cancer Research, April 12-16, 2008, San Diego, U.S.A.. 2008.

 

Pang R.T.K., Liu W., Chiu C.N., Lee C.K.F. and Yeung W.S.B., Microrna regulates notch1 receptor in hela cells, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Tam V.C.G., Chiu C.N., Koistinen R., Koistinen M., Seppala M., Ho P.C., Lee C.K.F. and Yeung W.S.B., Glycodelin-C receptor on human spermatozoa., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.459.

 

Wong B.S.T., Chiu C.N., Koistinen R., Koistinen H., Seppala M., Ho P.C., Lee C.K.F. and Yeung W.S.B., Priming effect of glycodelin-A on zona pellucida-induced acrosome reaction in human sperm, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Chow AMK



List of Research Outputs

 

Chow A.M.K., Choy M.Y. and Lao T.T.H., Effect of high glucose on cytokine profile in placental explants obtained from normal and gestational diabetic pregnancies, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Chow A.M.K., Choy M.Y. and Lao T.T.H., Effect of lipopolysaccharide on secretory cytokine profile of placental explants from normal and gestational diabetic pregnancies, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Researcher : Chow WN



List of Research Outputs

 

Lee C.Y.L., Chan Y.L., Chow W.N., Ng E.H.Y., Lee C.K.F., Yeung W.S.B. and Ho P.C., Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway., Fertility and Sterility. 2008.

 

Tse P.K., Lee Y.L., Chow W.N., Luk J.M.C., Lee K.F. and Yeung W.S.B., Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b, Endocrinology. 2008, 149(3): 1268-1276.

 

Researcher : Choy MY



Project Title:

An investigation of human placental insulin degrading enzyme in normal and diabetic pregnancies

Investigator(s):

Choy MY, Lao TTH

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

10/2005

 

Abstract:

Gestational diabetes mellitus (GDM) affects 12% of pregnant women and is associated with perinatal complications including macrosomia which is strongly associated with fetal death, prematurity, birth trauma and respiratory distress syndrome. More importantly, offspring of GDM have a higher risk of developing obesity, impaired glucose tolerance, and type 2 diabetes mellitus (DM2).1 As the interface between mother and fetus, the placenta is the obligatory target of adverse environmental changes in diabetic pregnancies. Although it is generally accepted that the hyperinsulinemia in DM2 is a compensatory response to insulin resistance of target tissues, there is increasing evidence that, at least in some populations, basal hyperinsulinemia itself can have a primary role in the pathogenesis of DM2. Insulin resistance has been reported to occur as a result of excessive insulin degradation.2 IDE (insulin-degrading enzyme) is a widely expressed zinc-metallopeptidase that has been shown to regulate both cerebral amyloid beta-peptide and plasma insulin levels in vivo. In vitro, IDE not only degrades insulin and glucagon, but also insulin growth factors I and II, the leader peptide of peroxysomal prethiolase ,transforming growth factor , the ß-amyloid peptide, and other peptides. 3 In addition to degradation, IDE has multiple cellular functions, including binding and regulatory functions, evidencing a more direct role of this enzyme in generating insulin effects. Currently, there is no information regarding the presence and activity of IDE in the placenta of human pregnancies. Given its importance as a candidate for insulin clearance and metabolism in other tissue systems and its association with DM2, we hypothesize that IDE could potentially play an important role in glucose metabolism in human pregnancy. We hypothesize that IDE is an important candidate for placental insulin degradation and that dysfunctional placental IDE production is involved in pregnancies complicated by diabetes. Therefore the aims and objectives of the project are as follows: i) to determine the expression and localization of IDE in normal first and third trimester placenta; ii) to determine the expression and localization of IDE of gestational diabetic placenta at term; iii) to determine by using in-vitro explant and cell line models whether abnormal placental IDE production is induced by hyperglycaemia. Key issues: The following issues will be addressed in this project: i) Does the human placenta produce IDE throughout pregnancy? And if so, to identify the cellular source of IDE production ii) Is IDE production gestationally regulated? iii) Is IDE production impaired in GDM placentae? iv) Can we model the effects of GDM on IDE production in-vitro? References 1. Allen SR. 2003. Gestational diabetes: a review of the treatment options. Treat Endocrinol; 2(5): 357-65 2. Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, Eckman CB, Tanzi 3. RE, Selkoe DJ. 2004. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol; 164(4): 1425-34 3. Duckworth, W.C., R.G. Bennett & F.G. Hamel. 1998. Insulin degradation: progress and potential. Endocr. Rev. 19; 608-624.

 

List of Research Outputs

 

Chow A.M.K., Choy M.Y. and Lao T.T.H., Effect of high glucose on cytokine profile in placental explants obtained from normal and gestational diabetic pregnancies, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Chow A.M.K., Choy M.Y. and Lao T.T.H., Effect of lipopolysaccharide on secretory cytokine profile of placental explants from normal and gestational diabetic pregnancies, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Choy M.Y., Kwok K.L. and Lao T.T.H., Effect of hyperglycemia on insulin degrading enzyme and insulin receptor substrates 1 & 2 in human first trimester trophoblasts, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Researcher : Chung MK



List of Research Outputs

 

Chiu C.N., Wong B.S., Lee C.L., Chung M.K., Lam K.K., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Purification of native human zona pellucida glycoproteins from eggs: Binding characteristics to human spermatozoa, hyper-activation, acrosomal exocytosis, and sperm-oocyte interaction. P.74, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Lee C.K.F. and Yeung W.S.B., Cumulus ooporous-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. O.2.05, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Purification and identification of a glycodelin-C interacting protein from human cumulus matrix, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K., Lee C.L., Pang R., Lee C.K.F. and Yeung W.S.B., Study of the interaction of cumulus-associated alpha-2-macroglobulin with glycodelin-C from human cumulus matrix. P. 196, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., Differential glycosylation regulates the immunosuppressive activities of glycodelins. P3.11, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Lee C.L., Chiu C.N., Chung M.K., Lam K.K., Chu I.K., Lee C.K.F., Lao T.T.H. and Yeung W.S.B., Impaired immunosuppressive activities of glycodelin-A in pregnant women with gestational diabetes mellitus. P.611, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., The immunosuppressive effect of glycodelin-A from amniotic fluid, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Gao J



List of Research Outputs

 

Ng E.H.Y., So W.Z., Gao J., Wong Y.Y. and Ho P.C., The role of acupuncture in the management of subfertility, Fertility and Sterility. 2008, 90: 1-13.

 

Researcher : Ho PC



Project Title:

Endocrine gland derived vascular endothelial growth factor (EG-VEGF) in human endometrium

Investigator(s):

Ho PC, Ngan ESW, Ng EHY, Yeung WSB

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Competitive Earmarked Research Grants (CERG)

Start Date:

10/2004

 

Abstract:

To examine the temporal and spatial expression pattern of EG-VEGF and its receptors in human endometrium; to elucidate the mitogenic and angiogenic properties of EG-VEGF in human endometrial microvascular endothelial cell (hEMVEC); to study the expression of EG-VEGF in patients with endometriosis.

 

Project Title:

Will letrozole improve the ovarian response in women with poor ovarian reserve who are undergoing IVF treatment?

Investigator(s):

Ho PC, Tang OS

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

07/2005

 

Abstract:

Letrozole is a non-steroidal reversible, competitive aromatase inhibitor that is highly potent and selective. It has a short half-life of around 45 hours (Sioufi et al., 1997). The rapid elimination from the body and the absence of estrogen receptor down-regulation effect as observed in clomiphene citrate treatment allow adequate time for the endometrium to regenerate from the anti-estrogen effect of the drug and therefore enhances implantation. The mechanism of action of letrozole in ovulation induction is proposed to be due to the selective inhibition of the aromatase enzyme that catalyzes the rate-limiting step in the conversion of androstenedione and testosterone to estrone and estradiol respectively. Treatment with an aromatase inhibitor in the early part of the menstrual cycle will decrease estrogen synthesis and hence the negative feedback centrally, resulting in increased gonadotrophin secretion. Moreover, by blocking the conversion of androgens to estrogens in the ovary, the accumulating intra-ovarian androgens may increase follicular sensitivity through amplification of FSH receptor gene expression (Weil et al., 1998; 1999; Vendola et al., 1998; 1999).

 

Project Title:

Role of olfactomedin in implantation

Investigator(s):

Ho PC, Lee CKF, Ng EHY, Yeung WSB

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Competitive Earmarked Research Grants (CERG)

Start Date:

01/2006

 

Abstract:

To study the expression of olfactomedin in different phases of the reproductive cycle; to determine the site of olfactomedin biosynthesis; to study the role of steroid in the regulation of olfactomedin biosynthesis; to study the role of the molecule in embryo adhesion and trophoblast invasion.

 

Project Title:

A pilot study on the use of letrozole and misoprostol for the termination of second trimester pregnancy

Investigator(s):

Ho PC, Tang FOS

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

09/2006

 

Abstract:

Objectives: Misoprostol with or without mifepristone has been used for medical abortion in the second trimester. Pre-treatment with mifepristone resulted in a shorter induction-to-abortion interval as compared with regimens without mifepristone (El-Rafaey et al, 1995; Ho et al, 1996; Wong et al, 2000; Ashok et al, 1999). Studies carried out in early 1980s demonstrate that the efficacy of mifepristone alone in inducing complete abortion in the first trimester is at most 60-80% in the human. Dr Garfield R et al. have demonstrated recently that certain compounds in combination with an antiprogestin can significantly improve abortifacient efficacy. For example, when low doses of mifepristone (which alone have no effect on pregnancy) have been combined with low doses iNOS inhibitors or aromatase inhibitors or progesterone synthesis inhibitors, which again alone have no effect, a tremendous synergistic effect has been seen in the mouse, the rat and the guinea pig.(Garfield, unpublished) Abortion rates have been up to 100%, there has been a complete evacuation of the uterus soon after the treatment and the duration of bleeding has been surprisingly short. Letrozol is an aromatase inhibitor used to treat estrogen-dependent breast cancer. It is a third generation aromatase inhibitor. Aromatase, an enzyme of cytochorme P450 superfamily and the product of CY195 gene, is highly expressed in the placenta and granulosa cells of ovarian origin. Aromatase is also present in several non-glandular tissue including subcutaneous fat, liver, muscle, brain, normal breast, and breast-cancer tissue. Residual estrogen production after menopause is solely from nonglandular sources (Miller et al, 1982 & Nelson et al, 2001). In premenopausal women, the use of aromatase inhibitors leads to an increase in gonadotropin secretion because of the reduced feedback of estrogen to the hypothalamus and pituitary. The short-term application of letrozole has recently been successful for the induction of ovulation in women with infertility and dosage up to 7.5mg has been used (Mitwally et al, 2002. Al-Fozan et al., 2004). Third generation aromatase inhibitors have specific action at clinical doses and they have no effect on basal levels of cortisol and aldosterone (Plourde et al, 1995; Bajetta et al, 2000 & Bisagni et al, 1996). Estrogen and progesterone are important hormones for pregnancy. The use of aromatase inhibitor may cause a decrease in estrogen production by the corpus luteum and the placenta and thus results in abortion. The use of letrozole may potentiate the effect of prostaglandin and thus, can shorten the induction to abortion interval and increase the success rate. We are proposing a pilot study to investigate the effect of the combination of letrozole and misoprostol in the termination of second trimester pregnancy: a single dose of 7.5mg letrozol on Day 1 and Day 2 followed by repeated doses of 0.4 mg misoprostol from Day 3. The objective of the present pilot study is to test whether the aromatase inhibitor, letrozole, have a synergistic effect when used with misoprostol for the termination of second trimester pregnancy in women at 12 to 20 weeks of gestation. This treatment regimen will be studied and the following outcomes will be assessed: (i) their capability of inducing abortion (ii) the induction-to-abortion interval; and (iii) the frequency of side effects Reference: 1. Al-Fozan H, Al-Khadouri M , Tan ST, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fert. Steril. 2004, 84, 1561-3. 2. Ashok PW & Templeton A. (1999) Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol., 106, 706-10. 3. Bajetta E, Zilembo N, Bischisao E, et al. (2000) Tumour response and estrogen suppression in breast cancer patients treated with aromatase inhibitors. Ann Onco., 11, 1017-22. 4. Bisagni G, Cocconi G, Scaglione F, Fasichini F, Pfister C, Trunet PF. Letrozole, a new oral non-steroidal aromatase inhibitor in treating postmenopausal patients with advanced breast cancer: a pilot study. (1996) Ann onco., 7, 99-102. 5. El-Rafaey H and Templeton A. (1995) Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum. Reprod., 10, 475-8. 6. Ho PC, Chan YF, Lau W. (1996) Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomized comparative trial. Contraception, 53, 281-3. 7. Miller WR, Hawkins RA, Forrest AP. (1982) Significance of aromatase inhibitors in human breast cancer. Cancer Res., 42 suppl, 3365s-3368s. 8. Nelson LR, Bulun SE. Estrogen production and action. (2001) J Am Acad Dermatol., 45 suppl: S116-S124. 9. Mitwally MF, Casper RF. (2002) Aromatase inhibitor for ovarian stimulation: future avenue for infertility management. Curr Opin Obstet Gynecol., 14, 255-63. 10 Plourde PV, Dyroff M, Dowsett M. Demers L, Yates R, Webster A. (1995) ARIMIDEX: a new oral, once-a-day aromatase inhibitor. J Steroid Biochem Mol Biol., 53, 175-9. 11. Wong KS, Ngai CSW, Yeo ELK, Tang LCH. (2000) A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum. Reprod., 15, 709-12.

 

Project Title:

Adrenomedullin and sperm functions

Investigator(s):

Ho PC, Yeung WSB, Chiu CN, Lee CKF, Tang F

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Competitive Earmarked Research Grants (CERG)

Start Date:

01/2007

 

Abstract:

To determine the effect of adrenomedullin on sperm functions; to study the effect of adrenomedullin on the spermatozoa from patients with mild fertilization problem; to investigate the signaling pathways of adrenomedullin in spermatozoa.

 

List of Research Outputs

 

Blum J., Winikoff B., Gemzell-Danielsson K., Ho P.C., Schiavon R. and Weeks A., Treatment of incomplete abortion and miscarriage with misoprostol, International Journal of Gynecology and Obstetrics. 2007, 99 (Supplement 2): S186-S189.

 

Chan V.N.Y., Ng E.H.Y., Yeung W.S.B., Yam I.Y.L., Chan T.K. and Ho P.C., Preimplantation genetic diagnosis of thalassaemias, 11th Congress of the International Society of Hematology, Asian-Pacific Division (ISH-APD2007) and the 12th Congress of the Asian-Pacific Bone Marrow Transplantation, Beijing, China, September 21-23. 2007.

 

Gemzell-Danielsson K., Ho P.C., Gomez Ponce de Leon R., Weeks A. and Winikoff B., Misoprostol to treat missed abortion in the first trimester, International Journal of Gynecology and Obstetrics. 2007, 99 (Supplement 2): S182-S185.

 

Ho P.C., "New frontiers of assisted reproductive technology", CT Hsu Memorial Lecture, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, AOCOG 2007 Golden Jubilee of Federation, September 21-25, 2007, Tokyo, Japan. 2007.

 

Ho P.C., Associate Editor, Human Reproduction. 2007.

 

Ho P.C., Director of Editorial Board in Obstetrics and Gynaecology, Journal of Paediatrics, Obstetrics and Gynaecology, 1997 till now. 2007.

 

Ho P.C., Emergency contraception: Does improved access reduce the pregnancy rate?, Gynecological Endocrinology. 2007, 23(9): 497-498.

 

Ho P.C., Hong Kong experience with misoprostol alone, Meeting on Strategies and Guidelines for the Safe Second Trimester Abortion in India, New Delhi, India, June 29-30, 2008. 2008.

 

Ho P.C. and Hui P.W., Limitations of first trimester screening for Trisomy 21 after IVF, 2007 Annual Scientific Meeting, The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Queensland, Australia, October 2-5, 2007. 2007.

 

Ho P.C., Management of infertility in PCOS, Scientific Symposium of "Innovative Approaches to Women's Health", Cebu, Philippines, January 4, 2008. 2008.

 

Ho P.C., Management of subfertility in polycystic ovary syndrome, 41st Annual Scientific Sessions 2008, Sri Lanka College of Obstetricians and Gynaecologists, Sri Lanka, June 27-29, 2008, 30(Suppl):6-7. 2008.

 

Ho P.C., Member of Editorial Board, "Hospital Practice and Infection Control", 1989 till now. 2008.

 

Ho P.C., Member of Editorial Board, Chinese Journal of Obstetrics and Gynaecology. 2007.

 

Ho P.C., Member of Editorial Board, Clinical Obstetrics and Gynaecology (Bailliere Tindall). 2007.

 

Ho P.C., Member of Editorial Board, Journal of Assisted Reproduction and Genetics. 2007.

 

Ho P.C., Member of Editorial Board, Journal of Practical Obstetrics and Gynaecology. 2007.

 

Ho P.C., Member of Editorial Board, Journal of Reproductive Medicine (China). 2007.

 

Ho P.C., Member of the Advisory Editorial Board, Asia Oceania Journal of Obstetrics and Gynaecology, 1994 till now. 2008.

 

Ho P.C., Misoprostol - An essential drug in Obstetrics and Gynaecology, William Meredith Fletcher Shaw Memorial Lecture , 31st The British International Congress of Obstetrics and Gynaecology, July 4-6, 2007, Excel, London, United Kingdom, S.2.5. 2007.

 

Ho P.C., Blumenthal P.D., Gemzell-Danielsson K., Gomez Ponce de Leon R., Mittal S. and Tang F.O.S., Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks, International Journal of Gynecology and Obstetrics. 2007, 99 (Supplement 2): S178-S181.

 

Ho P.C., Ovarian stimulation and endometrial receptivity, Abstract in the 2008 Beijing International Congress on Human Reproductive Medicine and the 20th Anniversary Celebration for the Birth of First IVF-baby on China's Mainland, Beijing, China, February 24-26, 2008.

 

Ho P.C., Recent advances of medical abortion (PS99), Gynecological Endocrinology. 2008, 24 (Supplement No.1): 57.

 

Ho P.C., Recent advances of medical abortion, 13th World Congress of Gynecological Endocrinology, Florence, Italy, February 28 - March 2, 2008.

 

Ho P.C., Reviewer for "American Journal of Obstetrics and Gynaecology". 2008.

 

Ho P.C., Reviewer for "Biology of Reproduction". 2008.

 

Ho P.C., Reviewer for "Obstetrics and Gynaecology". 2008.

 

Lee C.Y.L., Chan Y.L., Chow W.N., Ng E.H.Y., Lee C.K.F., Yeung W.S.B. and Ho P.C., Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway., Fertility and Sterility. 2008.

 

Leung W.C., Lam Y.H., Leung T.W. and Ho P.C., A pilot study on the prevalence of domestic violence against male partners of pregnant women in Hong Kong, The Hong Kong Medical Diary. 2007, 12(7): 25-27.

 

Liu Y., Ng E.H.Y., Yeung W.S.B., Ho P.C. and Lee C.K.F., The expression and functional studies of DKK1 and Wnt signaling molecules in human endometrium and embryo implantation. O2.16., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Ng E.H.Y., Chan C.C.W., Tang F.O.S. and Ho P.C., Comparison of 2-Dimensional, 3-Dimensional, and vascular ultrasonographic parameters for endometrial receptivity between 2 consecutive stimulated in vitro fertilization cycles, Journal of Ultrasound In Medicine. 2007, 26(7): 931-939.

 

Ng E.H.Y. and Ho P.C., Polycystic ovary syndrome in Asian women, Seminar In Reproductive Medicine. 2008, 26: 14-21.

 

Ng E.H.Y., Lau E.Y.L., Yeung W.S.B., Cheung T.M., Tang F.O.S. and Ho P.C., Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage, Fertility and Sterility. 2008, 89(5): 1147-1153.

 

Ng E.H.Y., So W.Z., Gao J., Wong Y.Y. and Ho P.C., The role of acupuncture in the management of subfertility, Fertility and Sterility. 2008, 90: 1-13.

 

Ng E.H.Y., Chan C.C.W., Tang F.O.S., Yeung W.S.B. and Ho P.C., The role of endometrial blood flow measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment, European Journal of Obstetrics and Gynecology and Reproductive Biology. 2007, 135: 8-16.

 

Ng P.P.Y., Tang M.H.Y., Lau E.T.K., Ng L.K.L., Ngan E.H.Y., Tam P.C., Yeung W.S.B. and Ho P.C., Chromosome anomalies and Y-microdeletions in subfertile men (Poster), The ACAG-HKSMG International Conference, Hong Kong, 11 June 2008.

 

Ng P.Y., Liu Y., Ng E.H.Y., Ho P.C., Yeung W.S.B. and Lee C.K.F., Differential gene expression of olfactomedin throughout the menstrual cycle is regulated by ovarian hormones., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.508.

 

Tam V.C.G., Chiu C.N., Koistinen R., Koistinen M., Seppala M., Ho P.C., Lee C.K.F. and Yeung W.S.B., Glycodelin-C receptor on human spermatozoa., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.459.

 

Tang F.O.S., Gemzell-Danielsson K. and Ho P.C., Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects, International Journal of Gynecology and Obstetrics. 2007, 99, Supplement 2: S160-S167.

 

Tang F.O.S., Vekemans M., Hertzen H. and Ho P.C., Termination of pregnancy in the first trimester with misoprostol alone, International Planned Parenthood Federation Medical Bulletin. 2008, 42(1): 3-4.

 

Tiwari A.F.Y., Fong D.Y.T., Chan E.K.L., Leung W.C., Parker B. and Ho P.C., Identifying intimate partner violence: Comparing the Chinese Abuse Assessment Screen with the Chinese Revised Conflict Tactics Scales, The 12th International Conference on Violence Abuse and Trauma. San Diego, USA, 2007.

 

Tiwari A.F.Y., Fong D.Y.T., Chan E.K.L., Leung W.C., Parker B. and Ho P.C., Identifying intimate partner violence: comparing the Chinese abuse assessment screen with the Chinese revised conflict tactics scales, British Journal of Obstetrics and Gynaecology. England, 2007, 114: 1065-1071.

 

Tiwari A.F.Y., Wong J.Y.H., Fong D.Y.T., Chan E.K.L., Leung W.C., Brownridge D.A. and Ho P.C., Intimate partner violence in obstetric/gynecology patients: a Chinese perspective, Expert Review of Obstetrics & Gynecology. 2008, 3(3): 317-330.

 

Tiwari A.F.Y., Chan E.K.L., Fong D.Y.T., Brownridge D.A., Lam H., Wong B., Lam C.M., Chan F., Chan A., Cheung K.B. and Ho P.C., The impact of psychological abuse by an intimate partner on the mental health of pregnant women, BJOG. Blackwell, 2008, 115: 377-384.

 

Wong B.S.T., Chiu C.N., Koistinen R., Koistinen H., Seppala M., Ho P.C., Lee C.K.F. and Yeung W.S.B., Priming effect of glycodelin-A on zona pellucida-induced acrosome reaction in human sperm, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Yao Y.Q., Lee C.K.F., Xu J.S., Ho P.C. and Yeung W.S.B., Effect of human oviductal embryotrophic factors on gene expression of mouse preimplantation embryos, Zhonghua Fu Chan Ke Za Zhi (Chinese). 2007, 42(9): 605-607.

 

Researcher : Hui PW



List of Research Outputs

 

Ho P.C. and Hui P.W., Limitations of first trimester screening for Trisomy 21 after IVF, 2007 Annual Scientific Meeting, The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Queensland, Australia, October 2-5, 2007. 2007.

 

Hui P.W., Leung W.C., Au W.Y., Chan C.P. and Lao T.T.H., A rare cause of thrombocytopenia in pregnancy – EDTA-dependent pseudothrombocytopenia, 31st British International Congress of Obstetrics and Gynaecology, 3 – 6 July 2007, London, United Kingdom. 2007.

 

Hui P.W. and Ngan H.Y.S., Discipline-based examination and generic assessment principles, 5th Asia Pacific Medical Education Conference (APMEC), 24-27 January, 2008, Singapore. 2008.

 

Hui P.W., Lam T.P.W., Chan K.L. and Lee C.P., Fetus in Fetu - from prenatal ultrasound and MRI diagnosis to postnatal confirmation, Prenatal Diagnosis. 2007, Issue 7, 27: 657 -661.

 

Researcher : Kwan TTC



List of Research Outputs

 

Kwan T.T.C., Chan K.K.L., Yip M.W., Tam K.F., Cheung A.N.Y., Young P.M.C., Lee P.W.H. and Ngan H.Y.S., Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative–quantitative study, Sex Transm Infect. 2008, 84(3): 227-232.

 

Ngan H.Y.S., Kwan T.T.C., Tam K.F., Chan K.K.L., Young P.M., Lo S.S., Cheung A.N.Y. and Lee P.W.H., Knowledge and attitute of Chinese women on cervical cancer and human papillomavirus, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, September 21-25, 2007, Tokyo, Japan. 2007.

 

Researcher : Kwok KL



List of Research Outputs

 

Choy M.Y., Kwok K.L. and Lao T.T.H., Effect of hyperglycemia on insulin degrading enzyme and insulin receptor substrates 1 & 2 in human first trimester trophoblasts, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Researcher : Lai KY



List of Research Outputs

 

Lee C.K.F., Wong B.P.C., Lai K.Y. and Yeung W.S.B., Cloning and characterization of oviductal demilune cell and parotid protein (Dcpp) gene promoter., The 23rd Annual Meeting of the european Society of Human Reproduction and Embryology. 2007.

 

Lee C.K.F., Wong B.P.C., Lai K.Y. and Yeung W.S.B., Cloning and characterization of oviductal demilune cell and parotid protein (Dcpp) gene promoter, The 23rd Annual Meeting of the european Society of Human Reproduction and Embryology. 2007.

 

Researcher : Lam KW



List of Research Outputs

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Lee C.K.F. and Yeung W.S.B., Cumulus ooporous-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. O.2.05, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Purification and identification of a glycodelin-C interacting protein from human cumulus matrix, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Ip P.P.C., Lam K.W., Cheung C.L., Yeung C.W., Pun T.C., Chan K.Y.Q. and Cheung A.N.Y., Tranexamic Acid-associated Necrosis and Intralesional Thrombosis of Uterine Leiomyomas: A Clinicopathologic Study of 147 Cases Emphasizing the Importance of Drug-induced Necrosis and Early Infarcts in Leiomyomas , American Journal of Surgical Pathology. 2007, 31(8): 1215-1224.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., Differential glycosylation regulates the immunosuppressive activities of glycodelins. P3.11, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., The immunosuppressive effect of glycodelin-A from amniotic fluid, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Lam KW



List of Research Outputs

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Lee C.K.F. and Yeung W.S.B., Cumulus ooporous-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. O.2.05, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Purification and identification of a glycodelin-C interacting protein from human cumulus matrix, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Ip P.P.C., Lam K.W., Cheung C.L., Yeung C.W., Pun T.C., Chan K.Y.Q. and Cheung A.N.Y., Tranexamic Acid-associated Necrosis and Intralesional Thrombosis of Uterine Leiomyomas: A Clinicopathologic Study of 147 Cases Emphasizing the Importance of Drug-induced Necrosis and Early Infarcts in Leiomyomas , American Journal of Surgical Pathology. 2007, 31(8): 1215-1224.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., Differential glycosylation regulates the immunosuppressive activities of glycodelins. P3.11, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., The immunosuppressive effect of glycodelin-A from amniotic fluid, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Lao TTH



Project Title:

Dietary caloric intake and the development of gestational diabetes mellitus in at-risk Chinese women

Investigator(s):

Lao TTH, Leung WC

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2002

 

Abstract:

To determine the relationship between daily total caloric intake in the third trimester and the development of gestational diabetes mellitus in at-risk pregnant Chinese women; to compare the roles of toal caloric intake versus the carbohydrate: protein: fat ratio in the daily diet and development of gestational diabetes mellitus in the at-risk Chinese women.

 

Project Title:

The role of adiponectin in the development of gestational diabetes mellitus and its effect on pregnancy outcome

Investigator(s):

Lao TTH, Lam KSL, Chan KKL

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2003

 

Abstract:

To determine if plasma adiponectin concentration is reduced, at the time of the oral glucose tolerance test (OGTT), in women who develop GDM in the latter half of pregnancy versus women with normal OGTT; to determine, following the diagnosis of GDM, whether the subsequent changes in adiponectin concentration is associated with obstetric complications and perinatal morbidity; to correlate circulatory concentration of adiponectin with polymorphisms and mutations in the apM1 gene in high risk women with and without GDM, and with the expression of adiponectin in subcutaneous and omental fat cells obtained from biopsy at the time of caesarean delivery for obstetric indications; to correlate antenatal adiponectin concentration and result of the genetic study with the postnatal glucose tolerance status in the women who have developed GDM.

 

Project Title:

A study on the interrelationship among insulin-like growth factors, apoptosis and proliferation of trophoblast, and placental size throughout pregnancy, and their effects on infant outcome, in normal and diabetic pregnancies

Investigator(s):

Lao TTH, Cheung PT, Cheung ANY, Leung WC, Lam HSW

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Competitive Earmarked Research Grants (CERG)

Start Date:

12/2003

 

Abstract:

To compare in the normal and diabetic pregnancies the relationship between ultrasound-estimated placenta size and its vasculature, and fetal size, with maternal circulatory levels of IGFs and IGFBPs in the three trimesters; to compare in the normal and diabetic pregnancies the relationship among placental expression of IGFs with placental apoptotic and proliferative indices and placental size at the time of delivery; to determine whether the interactions between IGFs and IGFBPs with placental growth and size in the different trimesters can be predictive of obstetric and perinatal complications; to determine whether the interactions between IGFs and IGFBPs with placental growth and size in the different trimesters can be predictive of fetal growth and size at birth; to examine the relationship between placental and newborn size with the placental expression of IGFs as well as the apoptotic and proliferative indices in normal and diabetic pregnancies.

 

Project Title:

Elevated TNF-α in gestational diabetes mellitus-cause or consequence?

Investigator(s):

Lao TTH, Leung WC, Ngai CSW

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2004

 

Abstract:

To determine and compare the serial changes in maternal blood level of TNF-α and its receptors, C-reactive protein (CRP) , and ferritin in relation to the development of gestational diabetes mellitus (GDM) in Chinese pregnant women with singleton and twin pregnancies; to determine the relationship between changes in maternal blood level of TNF-α and its receptors, CRP and ferritin with the occurrence of complicantions in Chinese pregnant women with and with and without GDM, and whether there is any difference between singleton and twin pregnancies. To correlate the levels of TNF-α and its receptors between maternal blood with cord blood, and between these two compartments with placental size and the placental expression of TNF-α and its receptors. To correlate maternal and cord blood, and placental TNF-α and its receptors with the infant birthweight and development of perinatal complications, and the determine if there is any difference between singleton and twin pregnancies.

 

Project Title:

The relationship between the antioxidant defense system with the development of gestational diabetes mellitus and its complications in the Chinese population.

Investigator(s):

Lao TTH

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

12/2005

 

Abstract:

Gestational diabetes mellitus (GDM) has become the leading medical complication in pregnancy in the local Chinese population, and despite satisfactory glycaemic control, maternal and perinatal complications cannot be eliminated. One of the metabolic disturbances now documented with diabetes mellitus in non-pregnant subjects is an increased oxidative stress. The standard approach in the management of GDM is to normalize blood glucose level with dietary and insulin treatment, but this may not be sufficient to counter the increased oxidative stress, and the persistent risk of maternal and perinatal complications could be related to inadequate defense against the increased oxidative stress in GDM. There has been minimal information about the natural antioxidant defense systems, such as the enzymes superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and especially thioredoxin reductase (TRx), in pregnancy with and without GDM, and there is no information on these systems in the infant at the time of birth. These enzyme systems are present in the placenta and can also be measured in peripheral blood. The present study is designed to investigate (1) the maternal antioxidant defense systems at the time of diagnosis of GDM, comparing between women with normal and abnormal glucose tolerance; (2) and its subsequent changes in relation to treatment and glycaemic control, (3) the changes in relation to pregnancy complications in women with and without GDM; and (4) the changes in the fetal compartment as reflected in cord blood and placental tissue.

 

List of Research Outputs

 

Chan C.P. and Lao T.T.H., Effect of parity and advanced maternal age on obstetric outcome, International Journal of Gynecology and Obstetrics. Elsevier Ireland Limited, 2008, 102: 237-241.

 

Chow A.M.K., Choy M.Y. and Lao T.T.H., Effect of high glucose on cytokine profile in placental explants obtained from normal and gestational diabetic pregnancies, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Chow A.M.K., Choy M.Y. and Lao T.T.H., Effect of lipopolysaccharide on secretory cytokine profile of placental explants from normal and gestational diabetic pregnancies, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Choy M.Y., Kwok K.L. and Lao T.T.H., Effect of hyperglycemia on insulin degrading enzyme and insulin receptor substrates 1 & 2 in human first trimester trophoblasts, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Hui P.W., Leung W.C., Au W.Y., Chan C.P. and Lao T.T.H., A rare cause of thrombocytopenia in pregnancy – EDTA-dependent pseudothrombocytopenia, 31st British International Congress of Obstetrics and Gynaecology, 3 – 6 July 2007, London, United Kingdom. 2007.

 

Lao T.T.H., Gestational Diabetes Mellitus - An Overview, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, September 21-25, 2007, Tokyo, Japan. 2007.

 

Lao T.T.H. and Ho L.F., Impact of chorioamnionitis on perinatal outcome in gestational diabetic pregnancies, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Lao T.T.H., Chan C.P., Leung W.C., Ho L.F. and Tse K.Y., Maternal hepatitis B infection and gestational diabetes mellitus, Journal of Hepatology. 2007, 47(1): 46-50.

 

Lao T.T.H. and Ho L.F., Relationship between chorioamnionitis and glycemic control in gestational diabetic pregnancies, International Federation of Placenta Associations Meetings (13th Meeting) in Kingston, Ontario, Canada, August 16-23, 2007.

 

Lee C.L., Chiu C.N., Chung M.K., Lam K.K., Chu I.K., Lee C.K.F., Lao T.T.H. and Yeung W.S.B., Impaired immunosuppressive activities of glycodelin-A in pregnant women with gestational diabetes mellitus. P.611, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Leung W.C., Lau E.T.K., Lau W.L., Tang R., Wong S.F., Lau T.K., Tse K.T., Wong S.F., To W.W.K., Ng L.K.L., Lao T.T.H. and Tang M.H.Y., Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?, Hong Kong Medical Journal. 2008, 14(1): 6-13.

 

Researcher : Lau ETK



List of Research Outputs

 

Leung W.C., Lau E.T.K., Lau W.L., Tang R., Wong S.F., Lau T.K., Tse K.T., Wong S.F., To W.W.K., Ng L.K.L., Lao T.T.H. and Tang M.H.Y., Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?, Hong Kong Medical Journal. 2008, 14(1): 6-13.

 

Ng P.P.Y., Tang M.H.Y., Lau E.T.K., Ng L.K.L., Ngan E.H.Y., Tam P.C., Yeung W.S.B. and Ho P.C., Chromosome anomalies and Y-microdeletions in subfertile men (Poster), The ACAG-HKSMG International Conference, Hong Kong, 11 June 2008.

 

Researcher : Lau EYL



List of Research Outputs

 

Ng E.H.Y., Lau E.Y.L., Yeung W.S.B., Cheung T.M., Tang F.O.S. and Ho P.C., Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage, Fertility and Sterility. 2008, 89(5): 1147-1153.

 

Researcher : Lau WL



List of Research Outputs

 

Leung W.C., Lau E.T.K., Lau W.L., Tang R., Wong S.F., Lau T.K., Tse K.T., Wong S.F., To W.W.K., Ng L.K.L., Lao T.T.H. and Tang M.H.Y., Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?, Hong Kong Medical Journal. 2008, 14(1): 6-13.

 

Researcher : Lee CKF



Project Title:

Identification of implantation-related genes in mouse uterus: an genomic approach

Investigator(s):

Lee CKF, Yeung WSB, Yang ZM

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2004

 

Abstract:

To identify genes that are more directly related to implantation by using LCM. mRNA from specific endometrial cells around the implantation sites of mouse at Day 5.5 of pregnancy will be compared with endometrial cells at the inter-implantation site of the deciduas.

 

Project Title:

The molecular interaction between human oviductal embryotrophic factor-3 and embryo

Investigator(s):

Lee CKF, Luk JMC, Yeung WSB

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Competitive Earmarked Research Grants (CERG)

Start Date:

01/2005

 

Abstract:

To compare the fecundity of normal and C3-deficient mice; to determine the role of complement activation in the embryotrophic activity of C3; to determine the machinery for the conversion of C3/C3 to iC3b in the oviduct cell coculture system; to define the fragment of iC3b responsible for the embryotrophic activity of the molecule.

 

Project Title:

Cloning and functional characterization of demilune cell and parotid protein (Dcpp) gene promoter

Investigator(s):

Lee CKF, Yeung WSB

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

01/2006

 

Abstract:

The objectives of my proposal are (1) to isolate the promoter region of the mouse demilune cell and parotid protein (Dcpp) gene promoter, and (2) to characterise the hormonal regulation of the isolated promoter regions by transfection studies. Demiline cell and parotid protein (acc. no.: NM_019910, Dcpp, as named as p20) was first isolated from both sublingual demilune cells and parotid intercalated duct cells in mouse salivary glands [1] and shared very high homology (99% aa identity) with the common salivary gland 1 (acc. no.: S76879, CSP1) protein. The gene coding for Dcpp was located on chromosome 17A3.3 and encodes a 150aa polypeptide. Recently, we used suppression subtractive hybridization (SSH) to compare the gene expression patterns of oviduct containing-developing embryo, with the contralateral oviduct containing-oocyte to isolate genes that are up-regulated in the presence of developing embryo [2, 3]. One gene homologous to Dcpp was found to be highly upregulated in the oviductal epithelium containing developing embryo, and is under steroid hormone control in ovariectomized mouse model in vivo [4]. Bioinformatics search identified a human CSP1 homolog (acc. no.: NM_145252). In order to identify the region and understand the hormonal regulation of this gene in the oviduct during pre-implantation period, we propose to clone the Dcpp promoter and study its regulation in vitro. References: [1] Bekhor I et al. (1994) cDNA cloning, sequencing and in situ localization of a transcript specific to both sublingual demilune cells and parotid intercalated duct cells in mouse salivary glands. Arch Oral Biol 39, 1011-1022. [2] Lee KF et al. (2002) Early developing embryos affect the gene expression patterns in the mouse oviduct. Biochem. Biophys. Res. Commun. 292, 564-570. [3] Lee KF et al. (2005) Phospholipid transfer protein (PLTP) mRNA expression is stimulated by developing embryos in the oviduct. J. Cell. Biochem. 95, 740-749. [4] Lee KF et al. (2005) Demilune Cell Parotid Protein (Dcpp) from Murine Oviductal Epithelium Stimulates Pre-implantation Embryo Development. Endocrinology, in revision.

 

Project Title:

Functional characterization of VAD1.3, a novel acrosome-specific protein by conditional tissue-specific gene inactivation

Investigator(s):

Lee CKF, Cheah KSE, Yeung WSB, Luk JMC, Lee PY

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Competitive Earmarked Research Grants (CERG)

Start Date:

01/2006

 

Abstract:

To generate VAD1.3 knockout targeting construct; to generate VAD1.3 knockout mice; to produce antibodies against mouse VAD1.3; to analysis the VAD1.3 knockout mice.

 

Project Title:

Functional characterization of a testis-specific Trs4 gene on spermatogenesis by tissue-specific conditional inactivation

Investigator(s):

Lee CKF, Yeung WSB, Cheah KSE

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

NSFC/RGC Joint Research Scheme

Start Date:

01/2007

 

Abstract:

To characterize monoclonal antibodies against TRS4; to determine the interacting partners of TRS4; to generate TRS4 conditional knockout targeting construct; to generate TRS4 conditional knockout mice; to phenotype the TRS4 knockout mice.

 

List of Research Outputs

 

Aflatoonian R., Ward J., Lee C.K.F., Yeung W.S.B., Tsao S.W., Elliott S. and Fazeli A., Sex hormones enhance TLR3 response to its specific ligand in human fallopian tube epithelial cells. P.608, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Cheong A.W.Y., Lee C.Y.L., Liu W., Yeung W.S.B. and Lee C.K.F., Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Cheong W.Y.A., Lee C.Y.L., Liu Y., Yeung W.S.B. and Lee C.K.F., Best poster presentation award HKSEMR 2007- Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production. , The Annual Scientific Meeting of the Hong Kong Society of Endocrinology, Metabolism and Reproduction, 11 November 2007, Hong Kong.. 2007.

 

Chiu C.N., Wong S.T., Lee C.L., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Native human zona pellucida glycoproteins: purification and binding properties, Human Reproduction. 2008, 23: 1385.

 

Chiu C.N., Wong B.S., Lee C.L., Chung M.K., Lam K.K., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Purification of native human zona pellucida glycoproteins from eggs: Binding characteristics to human spermatozoa, hyper-activation, acrosomal exocytosis, and sperm-oocyte interaction. P.74, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Lee C.K.F. and Yeung W.S.B., Cumulus ooporous-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. O.2.05, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Purification and identification of a glycodelin-C interacting protein from human cumulus matrix, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K., Lee C.L., Pang R., Lee C.K.F. and Yeung W.S.B., Study of the interaction of cumulus-associated alpha-2-macroglobulin with glycodelin-C from human cumulus matrix. P. 196, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.K.F., Wong B.P.C., Lai K.Y. and Yeung W.S.B., Cloning and characterization of oviductal demilune cell and parotid protein (Dcpp) gene promoter., The 23rd Annual Meeting of the european Society of Human Reproduction and Embryology. 2007.

 

Lee C.K.F., Wong B.P.C., Lai K.Y. and Yeung W.S.B., Cloning and characterization of oviductal demilune cell and parotid protein (Dcpp) gene promoter, The 23rd Annual Meeting of the european Society of Human Reproduction and Embryology. 2007.

 

Lee C.K.F., Zuo Y., Tam B.Y., Tang A.Y.B. and Yeung W.S.B., Syntaxin and b-actin interact with acrosome-expressing protein VAD1.2/AEP2 in spermatogenesis. P.282, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.K.F., Zuo Y., Tam Y.T., Tang A.Y.B. and Yeung W.S.B., The acrosome-expressing proteins VAD1.3/AEP1 and VAD1.2 interact with syntaxin and b-acting in vitro., The Hong Kong Society of Endocrinology, Metabolism and Reproduction Annual Scientific Meeting. 2007.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., Differential glycosylation regulates the immunosuppressive activities of glycodelins. P3.11, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Lee C.L., Chiu C.N., Chung M.K., Lam K.K., Chu I.K., Lee C.K.F., Lao T.T.H. and Yeung W.S.B., Impaired immunosuppressive activities of glycodelin-A in pregnant women with gestational diabetes mellitus. P.611, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., The immunosuppressive effect of glycodelin-A from amniotic fluid, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Lee C.Y.L., Liu Y., Ng P.Y., Lee C.K.F., Au C.L., Ng E.H.Y. and Yeung W.S.B., Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation, Human Reproduction. 2008, 23: 894-903.

 

Lee C.Y.L., Chan Y.L., Chow W.N., Ng E.H.Y., Lee C.K.F., Yeung W.S.B. and Ho P.C., Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway., Fertility and Sterility. 2008.

 

Lin S.S.W., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Microrna expression profile and their regulatory roles in ovarian folliculogenesis , Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Liu Y., Ng E.H.Y., Yeung W.S.B., Ho P.C. and Lee C.K.F., The expression and functional studies of DKK1 and Wnt signaling molecules in human endometrium and embryo implantation. O2.16., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Monkkonen K.S., Aflatoonian R., Lee C.K.F., Yeung W.S.B., Tsao G.S.W., Laitinen J.T. and Fazeli A., Hormonal regulation of G{alpha}i2 and mPR{alpha} in immortalized human oviductal cell line OE-E6/E7., Mol Hum Reprod. 2007, 13: 845-51.

 

Ng P.Y., Liu Y., Ng E.H.Y., Ho P.C., Yeung W.S.B. and Lee C.K.F., Differential gene expression of olfactomedin throughout the menstrual cycle is regulated by ovarian hormones., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.508.

 

Pang R.T.K., Liu W., Chiu C.N., Lee C.K.F. and Yeung W.S.B., Microrna regulates notch1 receptor in hela cells, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Tam V.C.G., Chiu C.N., Koistinen R., Koistinen M., Seppala M., Ho P.C., Lee C.K.F. and Yeung W.S.B., Glycodelin-C receptor on human spermatozoa., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.459.

 

Wong B.S.T., Chiu C.N., Koistinen R., Koistinen H., Seppala M., Ho P.C., Lee C.K.F. and Yeung W.S.B., Priming effect of glycodelin-A on zona pellucida-induced acrosome reaction in human sperm, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Yan Z., Tam Y.T., Cheah K.S.E., Yeung W.S.B. and Lee C.K.F., Functional characterization of VAD 1.3 /AEP 1 Gene in acrosome-formation and fertility, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Yao Y.Q., Lee C.K.F., Xu J.S., Ho P.C. and Yeung W.S.B., Effect of human oviductal embryotrophic factors on gene expression of mouse preimplantation embryos, Zhonghua Fu Chan Ke Za Zhi (Chinese). 2007, 42(9): 605-607.

 

Zuo Y., Tam Y.T., Yeung W.S.B. and Lee C.K.F., Functional characterization of VAD1.3/AEP1 gene in acrosome-formation and fertility. O2.15., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Researcher : Lee CL



List of Research Outputs

 

Chiu C.N., Wong S.T., Lee C.L., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Native human zona pellucida glycoproteins: purification and binding properties, Human Reproduction. 2008, 23: 1385.

 

Chiu C.N., Wong B.S., Lee C.L., Chung M.K., Lam K.K., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Purification of native human zona pellucida glycoproteins from eggs: Binding characteristics to human spermatozoa, hyper-activation, acrosomal exocytosis, and sperm-oocyte interaction. P.74, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Lee C.K.F. and Yeung W.S.B., Cumulus ooporous-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. O.2.05, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Purification and identification of a glycodelin-C interacting protein from human cumulus matrix, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K., Lee C.L., Pang R., Lee C.K.F. and Yeung W.S.B., Study of the interaction of cumulus-associated alpha-2-macroglobulin with glycodelin-C from human cumulus matrix. P. 196, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., Differential glycosylation regulates the immunosuppressive activities of glycodelins. P3.11, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Lee C.L., Chiu C.N., Chung M.K., Lam K.K., Chu I.K., Lee C.K.F., Lao T.T.H. and Yeung W.S.B., Impaired immunosuppressive activities of glycodelin-A in pregnant women with gestational diabetes mellitus. P.611, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., The immunosuppressive effect of glycodelin-A from amniotic fluid, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Lee CL



List of Research Outputs

 

Chiu C.N., Wong S.T., Lee C.L., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Native human zona pellucida glycoproteins: purification and binding properties, Human Reproduction. 2008, 23: 1385.

 

Chiu C.N., Wong B.S., Lee C.L., Chung M.K., Lam K.K., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Purification of native human zona pellucida glycoproteins from eggs: Binding characteristics to human spermatozoa, hyper-activation, acrosomal exocytosis, and sperm-oocyte interaction. P.74, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Lee C.K.F. and Yeung W.S.B., Cumulus ooporous-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. O.2.05, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Purification and identification of a glycodelin-C interacting protein from human cumulus matrix, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K., Lee C.L., Pang R., Lee C.K.F. and Yeung W.S.B., Study of the interaction of cumulus-associated alpha-2-macroglobulin with glycodelin-C from human cumulus matrix. P. 196, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., Differential glycosylation regulates the immunosuppressive activities of glycodelins. P3.11, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Lee C.L., Chiu C.N., Chung M.K., Lam K.K., Chu I.K., Lee C.K.F., Lao T.T.H. and Yeung W.S.B., Impaired immunosuppressive activities of glycodelin-A in pregnant women with gestational diabetes mellitus. P.611, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., The immunosuppressive effect of glycodelin-A from amniotic fluid, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Lee CP



List of Research Outputs

 

Hui P.W., Lam T.P.W., Chan K.L. and Lee C.P., Fetus in Fetu - from prenatal ultrasound and MRI diagnosis to postnatal confirmation, Prenatal Diagnosis. 2007, Issue 7, 27: 657 -661.

 

Researcher : Lee CYL



Project Title:

Effects of C3 deficiency on preimplantation embryo development and implantation potential

Investigator(s):

Lee CYL, Yeung WSB, Lee CKF

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2005

 

Abstract:

Coculture of embryo with somatic cells is one of the methods to promote embryo development in vitro. We have shown previously that human oviductal epithelial cells secrete embryotrophic glycoproteins that stimulate the growth of mouse preimplantation embryos in vitro (1, 2). Embryotrophic factor-3 (ETF-3) is one of these factors. ETF-3. It enhances the development of mouse blastocysts resulting in blastocysts with more trophectoderm (TE) cells, larger diameter, higher hatching rate and hatched blastocyst with higher attachment potential and larger trophoblast outgrowth (3, 4). It also affects the expression of a number of genes (NKA-beta 1, PAR-2, cullin-1, ezrin, HSP-70, eIF-2 beta) in the treated blastocysts. Our laboratory recently identified ETF-3 to be complement 3. Its derivative, iC3b increases the preimplantation mouse embryo development in terms of higher blastulation rate, higher hatching rate and larger blastocyst size (5). The objective of this project is to study the effect of C3 knockout in the mouse on the development of the embryo. Similar study in human is difficult, if not impossible. 1. L. P. Liu, S. T. Chan, P. C. Ho, W. S. Yeung, Hum. Reprod 10, 2781 (1995). 2. L. P. Liu, S. T. Chan, P. C. Ho, W. S. Yeung, Hum. Reprod 13, 1613 (1998). 3. J. S. Xu, T. M. Cheung, S. T. Chan, P. C. Ho, W. S. Yeung, Biol Reprod 65, 1481 (2001). 4. Y. L. Lee et al., Biol Reprod 68, 375 (2003). 5. Y. L. Lee et al., J. Biol. Chem. (2003).

 

List of Research Outputs

 

Cheong A.W.Y., Lee C.Y.L., Liu W., Yeung W.S.B. and Lee C.K.F., Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Cheong W.Y.A., Lee C.Y.L., Liu Y., Yeung W.S.B. and Lee C.K.F., Best poster presentation award HKSEMR 2007- Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production. , The Annual Scientific Meeting of the Hong Kong Society of Endocrinology, Metabolism and Reproduction, 11 November 2007, Hong Kong.. 2007.

 

Lee C.Y.L., Liu Y., Ng P.Y., Lee C.K.F., Au C.L., Ng E.H.Y. and Yeung W.S.B., Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation, Human Reproduction. 2008, 23: 894-903.

 

Lee C.Y.L., Chan Y.L., Chow W.N., Ng E.H.Y., Lee C.K.F., Yeung W.S.B. and Ho P.C., Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway., Fertility and Sterility. 2008.

 

Researcher : Lee YL



List of Research Outputs

 

Tse P.K., Lee Y.L., Chow W.N., Luk J.M.C., Lee K.F. and Yeung W.S.B., Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b, Endocrinology. 2008, 149(3): 1268-1276.

 

Researcher : Lee YW



List of Research Outputs

 

Chan D.W., Lee Y.W., Liu V.W.S. and Ngan H.Y.S., Overexpression of AMPKgamma 2 enhances tumorigenicity of Ovarian Cancer Cells, Annual Meetings of American Association for Cancer Research, April 12-16, 2008, San Diego, CA, USA. 2008.

 

Researcher : Leung CY



List of Research Outputs

 

Leung C.Y., Liu S., Chan Y.K., Tam K.F., Chan K.K.L., Wong R.L.C. and Ngan H.Y.S., Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer, Oncology Reports. 2008, 19: 1339-1345.

 

Liu S., Tsang P.C.K., Chan Y.K., Cheung A.N.Y., Chan K.K.L., Leung C.Y. and Ngan H.Y.S., Distribution of Six Oncogenic Types of Human Papillomavirus and Type 16 Integration Analysis in Chinese Women with Cervical Precancerous Lesions and Carcinomas, Tumour Biol. 2008, 29(2): 105-113.

 

Ngan H.Y.S., Tsang P.C.K., Chan Y.K., Liu S., Cheung A.N.Y., Chan K.K.L. and Leung C.Y., Human papillomavirus genotyping and integration in cervical cancers and precursor lesions, 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November. 2007.

 

Researcher : Leung KY



List of Research Outputs

 

Leung K.Y., Tang M.H.Y. and Lam Y.H., Prenatal 2D and 3D ultrasound prediction of homozygous alpha thalassemia, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, September 21-25, 2007, Tokyo, Japan. 2007.

 

Leung K.Y., Cheong K.B., Tang M.H.Y. and Chan V.N.Y., Prenatal diagnosis of thalassemia, Journal of Paediatrics, Obstetrics & Gynaecology. 2008, 34: 37-42.

 

Tang G.W.K., Leung K.Y. and Chan C.C.W., Use of hormone therapy: POST-WHI ERA in Hong Kong, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, Tokyo, Japan September 21-25 . 2007.

 

Researcher : Leung THY



Project Title:

Functional characterization of DLC2 in suppression of cancer cell growth and tumorigenicity in liver cancer

Investigator(s):

Leung THY, Ng IOL

Department:

Pathology

Source(s) of Funding:

Small Project Funding

Start Date:

10/2006

 

Abstract:

The purpose of this study is to characterize the putative tumor suppressor gene, deleted in liver cancer 2, DLC2, functionally in liver cancer (hepatocellular carcinoma, HCC), which is a prevalent cancer in Southeast Asia including Hong Kong. Although the risk factors of HCC are well established, the underlying molecular mechanisms in the development of HCC remain largely unclear. In our previous study based on sequence homology with DLC1, we have identified a homolog and a putative tumor suppressor gene, deleted in liver cancer 2, DLC2 (Ching et al., 2003). From the genetic studies on DLC2, we have demonstrated that DLC2 is frequently underexpressed in HCC and a high incidence of allelic losses using loss of heterozygosity (LOH) assay on the chromosomal locus at 13q12.3. DLC2 encodes a Rho GTPase activating protein (RhoGAP) with GAP activity specific for RhoA and Cdc42 in vitro. In addition, our recent study has demonstrated DLC2 is a RhoGAP with specific suppression of RhoA activity in vivo (Leung et al., 2005b). We have also shown the effects and roles of DLC2 in suppressing cell growth, cell migration and cellular transformation (Leung et al, 2005b). The findings were novel. However, the molecular pathways underlying the role of DLC2 remain to be elucidated. Objectives: 1. To elucidate the role of DLC2 in HCC by RNA interference approach using shRNA 2. To delineate the underlying mechanism of DLC2 in cell growth suppression 3. To determine the clinicopathological significance of DLC2 in HCC Key issues and problems being addressed: Liver cancer is a major malignancy in the world and is particularly prevalent in this region, being the second commonest fatal cancer in Southeast Asia including Hong Kong. Despite definite improvements in the outcome of patients with HCC, so far, the overall prognosis of this cancer is still unsatisfactory because of late presentation and frequent tumor recurrence after surgical resection. New adjuvant treatment modalities for HCC are much awaited. In this regard, knowledge of the molecular and cellular targets underlying the development and progression of HCC is of importance as this can provide novel opportunities for therapeutic interventions for this cancer. In studying the molecular pathways that DLC2 participates in the suppression of tumor cell growth, we found that DLC2 can suppress the activity of a ribosomal kinase p70S6K in DLC2 stably transfected clones. However, the detail mechanisms of how DLC2 inhibits the activity of p70S6K remain unclear. The upstream player of p70S6K is the mammalian target of rapamycin (mTor). mTor is one of the regulators of p70S6K and is inhibited by a drug called rapamycin. The mTor-p70S6K signaling pathway is involved in the regulation of cell growth. In addition, p70S6K also plays a role in the MAPK/ERK signaling pathway in controlling cell differentiation and growth. Delineating the linkage between DLC2, p70S6K and MAPK/ERK will be curial in studying the function of DLC2 in cancer cell development.

 

List of Research Outputs

 

Leung T.H.Y., Yam J.W.P. and Ng I.O.L., STARD13 (StAR-related lipid transfer (START) domain containing 13). , Atlas Genet Cytogenet Oncol Haematol.. 2007.

 

Researcher : Leung TW



List of Research Outputs

 

Leung W.C., Lam Y.H., Leung T.W. and Ho P.C., A pilot study on the prevalence of domestic violence against male partners of pregnant women in Hong Kong, The Hong Kong Medical Diary. 2007, 12(7): 25-27.

 

Ngan H.Y.S., Liu S., Leung T.W., Cheung A.N.Y. and Chan Y.K., Study of human papillomavirus status in Southern Chinese women with normal cervix, precancerous cervical lesions and cervical cancers. , Health Research Symposium 2007: Building Bridges between research, practice and policy. September, Hong Kong. 2007.

 

Researcher : Leung TW



List of Research Outputs

 

Leung W.C., Lam Y.H., Leung T.W. and Ho P.C., A pilot study on the prevalence of domestic violence against male partners of pregnant women in Hong Kong, The Hong Kong Medical Diary. 2007, 12(7): 25-27.

 

Ngan H.Y.S., Liu S., Leung T.W., Cheung A.N.Y. and Chan Y.K., Study of human papillomavirus status in Southern Chinese women with normal cervix, precancerous cervical lesions and cervical cancers. , Health Research Symposium 2007: Building Bridges between research, practice and policy. September, Hong Kong. 2007.

 

Researcher : Leung WC



List of Research Outputs

 

Chan E.K.L., Brownridge D.A., Tiwari A.F.Y., Fong D.Y.T. and Leung W.C., Understanding violence against Chinese women in Hong Kong: An analysis of risk factors with a special emphasis on the role of in-law conflict, Violence Against Women. 2007, 2008 forthcoming.

 

Hui P.W., Leung W.C., Au W.Y., Chan C.P. and Lao T.T.H., A rare cause of thrombocytopenia in pregnancy – EDTA-dependent pseudothrombocytopenia, 31st British International Congress of Obstetrics and Gynaecology, 3 – 6 July 2007, London, United Kingdom. 2007.

 

Lao T.T.H., Chan C.P., Leung W.C., Ho L.F. and Tse K.Y., Maternal hepatitis B infection and gestational diabetes mellitus, Journal of Hepatology. 2007, 47(1): 46-50.

 

Leung W.C., Lam Y.H., Leung T.W. and Ho P.C., A pilot study on the prevalence of domestic violence against male partners of pregnant women in Hong Kong, The Hong Kong Medical Diary. 2007, 12(7): 25-27.

 

Leung W.C., Lau E.T.K., Lau W.L., Tang R., Wong S.F., Lau T.K., Tse K.T., Wong S.F., To W.W.K., Ng L.K.L., Lao T.T.H. and Tang M.H.Y., Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?, Hong Kong Medical Journal. 2008, 14(1): 6-13.

 

Tiwari A.F.Y., Fong D.Y.T., Chan E.K.L., Leung W.C., Parker B. and Ho P.C., Identifying intimate partner violence: Comparing the Chinese Abuse Assessment Screen with the Chinese Revised Conflict Tactics Scales, The 12th International Conference on Violence Abuse and Trauma. San Diego, USA, 2007.

 

Tiwari A.F.Y., Fong D.Y.T., Chan E.K.L., Leung W.C., Parker B. and Ho P.C., Identifying intimate partner violence: comparing the Chinese abuse assessment screen with the Chinese revised conflict tactics scales, British Journal of Obstetrics and Gynaecology. England, 2007, 114: 1065-1071.

 

Tiwari A.F.Y., Wong J.Y.H., Fong D.Y.T., Chan E.K.L., Leung W.C., Brownridge D.A. and Ho P.C., Intimate partner violence in obstetric/gynecology patients: a Chinese perspective, Expert Review of Obstetrics & Gynecology. 2008, 3(3): 317-330.

 

Researcher : Lin SSW



List of Research Outputs

 

Lin S.S.W., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Microrna expression profile and their regulatory roles in ovarian folliculogenesis , Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Liu S



List of Research Outputs

 

Chan K.K.L., Wei N., Liu S., Liao X., Cheung A.N.Y. and Ngan H.Y.S., Estrogen receptor subtypes in ovarian cancer: a clinical correlation, Obstet Gynecol. 2008, 111: 144-151.

 

Leung C.Y., Liu S., Chan Y.K., Tam K.F., Chan K.K.L., Wong R.L.C. and Ngan H.Y.S., Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer, Oncology Reports. 2008, 19: 1339-1345.

 

Liu S., Tsang P.C.K., Chan Y.K., Cheung A.N.Y., Chan K.K.L., Leung C.Y. and Ngan H.Y.S., Distribution of Six Oncogenic Types of Human Papillomavirus and Type 16 Integration Analysis in Chinese Women with Cervical Precancerous Lesions and Carcinomas, Tumour Biol. 2008, 29(2): 105-113.

 

Ngan H.Y.S., Tsang P.C.K., Chan Y.K., Liu S., Cheung A.N.Y., Chan K.K.L. and Leung C.Y., Human papillomavirus genotyping and integration in cervical cancers and precursor lesions, 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November. 2007.

 

Ngan H.Y.S., Liu S., Leung T.W., Cheung A.N.Y. and Chan Y.K., Study of human papillomavirus status in Southern Chinese women with normal cervix, precancerous cervical lesions and cervical cancers. , Health Research Symposium 2007: Building Bridges between research, practice and policy. September, Hong Kong. 2007.

 

Researcher : Liu VWS



Project Title:

Effect of controlled c-myc and p53 expression on mitochondrial biogenesis in ovarian cancer

Investigator(s):

Liu VWS, Ngan HYS

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Seed Funding Programme for Basic Research

Start Date:

03/2007

 

Abstract:

PURPOSE OF PROPOSED INVESTIGATIONRecently, the mitochondrial content changes in tumour have been found to correlate with the tumour behaviours. C-myc and p53 are demonstrated to be important in controlling mitochondrial biogenesis. The purpose of this proposal is to investigate the effect of c-myc and p53 expression on mitochondrial biogenesis in ovarian cancer.BACKGROUND AND HYPOTHESISIn 1930, Warburg hypothesized that cancer cells might have impaired mitochondrial function and sufficient ATP production for cell growth was mainly provided by an elevated glycolytic pathway. Nowadays, this so called "Warburg effect" was known to be a common characteristic of most tumours. Mitochondrial oxidative phosphorylation (OXPHOS) is the bioenergetic pathway for the synthesis of most ATP for normal cellular activities. The normal activity of OXPHOS is also required for the execution of cell apoptosis. Recently, a number of reports demonstrated the down-regulation of mitochondrial content but the presence of up-regulated glycolytic markers in several human cancers. Low mitochondrial content in tumor cell has been related to aggressive behavior of tumour. In addition to the nuclear-encoded polypeptide subunits of mitochondrial OXPHOS complexes, the mitochondrial genome encodes for 13 polypeptides that are subunits of complexes I, III, IV and V, respectively. Interestingly, both increased and decreased mitochondrial DNA (mtDNA) copy number and mitochondrial gene expression have been reported in human cancers. MtDNA mutations have also been demonstrated to cause cancer, increase tumourigenicity and promote cancer growth by prevention of apoptosis.Although the mechanism leading to the Warburg effect has not been clear for many years, increasing evidence suggests that abnormal expression of oncogenes such as c-myc and/or tumour suppressor genes such as p53 may be the underlying mechanism that drives the Warburg effect and eventually leads to tumour formation. Under normal circumstances, both c-myc and p53 have been found to regulate glycolysis and mitochondrial respiration.I have previously reported the occurrence of high frequency (60%) of somatic mtDNA mutations in ovarian cancer (1). In addition, it was found that mtDNA copy numbers in high grade ovarian tumors were significantly lower than that in low grade tumors (2). In an ongoing study, a few nuclear-encoded polypeptides of complex I was found to be down-regulated. I hypothesize that mitochondrial content change may play a significant role in ovarian cancer development. Furthermore, the c-myc gene has been found to be overexpressed or amplified in about 30-50% of ovarian cancer. And about 50% of human tumors lack a functional p53 gene. The most common subtype of ovarian cancer, high-grade serous carcinoma, is characterized by p53 mutations. I hypothesize that aberrant expression of c-myc and/or p53 may be responsible for the mitochondrial content changes in ovarian cancer.PROJECT OBJECTIVES:(1) To measure the levels of mitochondrial markers in various ovarian cancer cell lines and determine the potential roles of c-myc and p53 in mitochondrial biogenesis.(2) To study the effect of over-expression of c-myc or p53 on mitochondrial content.(3) To study the effect of inhibition of c-myc or p53 expression on mitochondrial content.From this proposed investigation, I expect to identify new mitochondrial markers which maybe potentially useful for clinical application and expect to find maybe one of the causes of mitochondrial dysfunction in ovarian cancer.

 

List of Research Outputs

 

Chan D.W., Lee Y.W., Liu V.W.S. and Ngan H.Y.S., Overexpression of AMPKgamma 2 enhances tumorigenicity of Ovarian Cancer Cells, Annual Meetings of American Association for Cancer Research, April 12-16, 2008, San Diego, CA, USA. 2008.

 

Liu V.W.S., Chan D.W., To M.Y., Chiu C.N. and Ngan H.Y.S., Forkhead box transcription factor FoxG1 is over-expressed in ovarian cancer and can inhibit p21 expression, Annual Meeting of the American Association for Cancer Research, April 12-16, 2008, San Diego, U.S.A.. 2008.

 

Tam C.W., Liu V.W.S., Leung W.Y., Yao K.M. and Shiu S.Y.W., The autocrine sPDZD2 protein is a potential p53 activator, AACR Centennial Conference on Translational Cancer Medicine: Technologies to Treatment. 2007, B40.

 

Yip C.T., Chan D.W., Liu V.W.S. and Ngan H.Y.S., Zic2 synergistically enhances Hedgehog signaling pathway in cervical cancer., The 12th Research Postgraduate Symposium 2007, The University of Hong Kong, Hong Kong, 12 Dec. 2007.. 2007.

 

Yip C.T., Chan D.W., Liu V.W.S. and Ngan H.Y.S., Zic2 synergistically enhances Hedgehog signaling pathway in cervical cancer., The 99th Annual Meeting of American Association of Cancer Research, 12-16 April 2008, San Diego, CA, USA.. 2008.

 

Researcher : Liu W



Project Title:

The regulatory effects of miRNA on preimplantation embryo developmen

Investigator(s):

Liu W, Yeung WSB, Lee CKF

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

09/2006

 

Abstract:

Purpose:miRNA are small molecules of 18-24 nucleotides in length and they have been demonstrate to regulate differentiation and developmental process. However, their role on pre-implantation embryo development is lacking. In this study, we aimed to study the expression and delineate the roles of miRNA during pre-implantation development, and study the effect of selected miRNA using in vitro functional assays.Objectives:1. To detect miRNA expression profiling of mouse embryo during preimplantation development (including unfertilized oocyte, 1-cell embryo, 2-cell embryo, 4-cell embryo, 8-cell embryo, morula and blastocyst);2. To examine the effects of seletected miRNA on pre-implantation mouse embryo development.Key issues and problems being addressed:1. To use multiplex miRNA assay to study the global expression of miRNA of mouse embryos in different developmental stages;2. Bioinformatics analysis of the qPCR results using statistical analysis tools and miRNA databases for target mRNA identification;3. Functional characterization of the selected genes on embryo development.

 

List of Research Outputs

 

Cheong A.W.Y., Lee C.Y.L., Liu W., Yeung W.S.B. and Lee C.K.F., Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Pang R.T.K., Liu W., Chiu C.N., Lee C.K.F. and Yeung W.S.B., Microrna regulates notch1 receptor in hela cells, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Liu Y



List of Research Outputs

 

Cheong W.Y.A., Lee C.Y.L., Liu Y., Yeung W.S.B. and Lee C.K.F., Best poster presentation award HKSEMR 2007- Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production. , The Annual Scientific Meeting of the Hong Kong Society of Endocrinology, Metabolism and Reproduction, 11 November 2007, Hong Kong.. 2007.

 

Lee C.Y.L., Liu Y., Ng P.Y., Lee C.K.F., Au C.L., Ng E.H.Y. and Yeung W.S.B., Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation, Human Reproduction. 2008, 23: 894-903.

 

Liu Y., Ng E.H.Y., Yeung W.S.B., Ho P.C. and Lee C.K.F., The expression and functional studies of DKK1 and Wnt signaling molecules in human endometrium and embryo implantation. O2.16., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Ng P.Y., Liu Y., Ng E.H.Y., Ho P.C., Yeung W.S.B. and Lee C.K.F., Differential gene expression of olfactomedin throughout the menstrual cycle is regulated by ovarian hormones., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.508.

 

Researcher : Liu Y



List of Research Outputs

 

Cheong W.Y.A., Lee C.Y.L., Liu Y., Yeung W.S.B. and Lee C.K.F., Best poster presentation award HKSEMR 2007- Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production. , The Annual Scientific Meeting of the Hong Kong Society of Endocrinology, Metabolism and Reproduction, 11 November 2007, Hong Kong.. 2007.

 

Lee C.Y.L., Liu Y., Ng P.Y., Lee C.K.F., Au C.L., Ng E.H.Y. and Yeung W.S.B., Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation, Human Reproduction. 2008, 23: 894-903.

 

Liu Y., Ng E.H.Y., Yeung W.S.B., Ho P.C. and Lee C.K.F., The expression and functional studies of DKK1 and Wnt signaling molecules in human endometrium and embryo implantation. O2.16., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Ng P.Y., Liu Y., Ng E.H.Y., Ho P.C., Yeung W.S.B. and Lee C.K.F., Differential gene expression of olfactomedin throughout the menstrual cycle is regulated by ovarian hormones., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.508.

 

Researcher : Ng EHY



Project Title:

Single or multiple biopsies for retrieval of spermatozoa from the testis?

Investigator(s):

 

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Other Funding Scheme

Start Date:

03/1999

 

Abstract:

To compare the recovery rate of testicular spermatozoa after single vs. multiple open testicular biopsies; to compare the testicular function after single vs. multiple open testicular biopsies.

 

Project Title:

To study the endometrial receptivity before and after removing intramural fibroids

Investigator(s):

 

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Other Funding Scheme

Start Date:

01/2000

 

Abstract:

To compare endometrial receptivity in patients having intramural fibroids before and after myomectomy.

 

Project Title:

A randomized comparison of side effects of two vaginal progesterone preparations used for luteal support in assisted reproduction cycles using pituitary down regulation

Investigator(s):

 

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Other Funding Scheme

Start Date:

07/2000

 

Abstract:

To compare the side effects of two vaginal progesterone preparations used for luteal support in assisted reproduction cycles using pituitary down regulation.

 

Project Title:

The value of increasing starting dose of gonadotrophin during ovarian stimulation in women with <= 6 antral follicles prior to stimulation

Investigator(s):

 

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Other Funding Scheme

Start Date:

08/2000

 

Abstract:

To determine the value of increasing starting dose of gonadotrophin during ovarian stimulation in women with <= 6 antral follicles prior to stimulation.

 

Project Title:

Comparison of the prevalence of polycystic ovary only and polycystic ovary syndrome between two different ethnic populations

Investigator(s):

Ng EHY, Chan CW

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

09/2005

 

Abstract:

The objective of this study is To define the prevalence of polycystic ovary only and polycystic ovary syndrome and its associated hormonal and biochemical profiles in Chinese and Indian populations.

 

Project Title:

The role of anti-Müllerian hormone in the prediction of livebirth rate and cumulative livebirth rate during in vitro fertilization treatment

Investigator(s):

Ng EHY, Yeung WSB, Ho PC

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

09/2006

 

Abstract:

To determine and compare the predictive values of serum FSH, serum AMH and AFC in livebirth and cumulative livebirth rates following in vitro fertilization treatment. This study will provide information on these predictive values and help in counselling patients with regard to the livebirth rate prior to the IVF treatment.

 

List of Research Outputs

 

Chan V.N.Y., Ng E.H.Y., Yeung W.S.B., Yam I.Y.L., Chan T.K. and Ho P.C., Preimplantation genetic diagnosis of thalassaemias, 11th Congress of the International Society of Hematology, Asian-Pacific Division (ISH-APD2007) and the 12th Congress of the Asian-Pacific Bone Marrow Transplantation, Beijing, China, September 21-23. 2007.

 

Lee C.Y.L., Liu Y., Ng P.Y., Lee C.K.F., Au C.L., Ng E.H.Y. and Yeung W.S.B., Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation, Human Reproduction. 2008, 23: 894-903.

 

Lee C.Y.L., Chan Y.L., Chow W.N., Ng E.H.Y., Lee C.K.F., Yeung W.S.B. and Ho P.C., Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway., Fertility and Sterility. 2008.

 

Liu Y., Ng E.H.Y., Yeung W.S.B., Ho P.C. and Lee C.K.F., The expression and functional studies of DKK1 and Wnt signaling molecules in human endometrium and embryo implantation. O2.16., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Ng E.H.Y., Assisted hatching, Asia Pacific Initiative on Reproduction (ASPIRE) and Pacific Rim Society for Fertility and Sterility (PRSFS), Singapore, April 10-13, 2008. 2008.

 

Ng E.H.Y., Chan C.C.W., Tang F.O.S. and Ho P.C., Comparison of 2-Dimensional, 3-Dimensional, and vascular ultrasonographic parameters for endometrial receptivity between 2 consecutive stimulated in vitro fertilization cycles, Journal of Ultrasound In Medicine. 2007, 26(7): 931-939.

 

Ng E.H.Y., Controversies in ART, Postgraduate Seminar organized by The Hong Kong College of Obstetricians and Gynaecologists, Hong Kong, November 11, 2007. 2007.

 

Ng E.H.Y., How to read a research paper?, HKCOG Research Course held by Hong Kong College of Obstetricians and Gynaecologists in Hong Kong, August 11, 2007. 2007.

 

Ng E.H.Y., New imaging techniques in ART-Road to success?, The Fourth Asian Fertility Expert Meeting, Beijing, China, September 7-8, 2007. 2007.

 

Ng E.H.Y. and Ho P.C., Polycystic ovary syndrome in Asian women, Seminar In Reproductive Medicine. 2008, 26: 14-21.

 

Ng E.H.Y., Lau E.Y.L., Yeung W.S.B., Cheung T.M., Tang F.O.S. and Ho P.C., Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage, Fertility and Sterility. 2008, 89(5): 1147-1153.

 

Ng E.H.Y., Role of ultrasound in determining ovarian reserve, Annual Scientific Meeting 2007 of The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Gold Coast, Australia, October 2-5, 2007. 2007.

 

Ng E.H.Y., So W.Z., Gao J., Wong Y.Y. and Ho P.C., The role of acupuncture in the management of subfertility, Fertility and Sterility. 2008, 90: 1-13.

 

Ng E.H.Y., Chan C.C.W., Tang F.O.S., Yeung W.S.B. and Ho P.C., The role of endometrial blood flow measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment, European Journal of Obstetrics and Gynecology and Reproductive Biology. 2007, 135: 8-16.

 

Ng E.H.Y., Treatment of repeated implantation failure, Symposium on Repeated Implantation Failure, held by 南方医科大學, 廣州, 中國. 2008.

 

Ng E.H.Y., Ultrasound in reproductive medicine, CME Programmes on Reproductive Medicine organized by Union Hospital, Hong Kong, June 6, 2008. 2008.

 

Ng E.H.Y., Use of three-dimensional ultrasound in assisted reproduction, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology organized by Asian and Oceanic Federation of Obstetrics and Gynaecology, Tokyo, Japan, September 21-25, 2007. 2007.

 

Ng P.Y., Liu Y., Ng E.H.Y., Ho P.C., Yeung W.S.B. and Lee C.K.F., Differential gene expression of olfactomedin throughout the menstrual cycle is regulated by ovarian hormones., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.508.

 

Researcher : Ng PPY



List of Research Outputs

 

Ng P.P.Y., Tang M.H.Y., Lau E.T.K., Ng L.K.L., Ngan E.H.Y., Tam P.C., Yeung W.S.B. and Ho P.C., Chromosome anomalies and Y-microdeletions in subfertile men (Poster), The ACAG-HKSMG International Conference, Hong Kong, 11 June 2008.

 

Researcher : Ng PY



List of Research Outputs

 

Lee C.Y.L., Liu Y., Ng P.Y., Lee C.K.F., Au C.L., Ng E.H.Y. and Yeung W.S.B., Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation, Human Reproduction. 2008, 23: 894-903.

 

Ng P.Y., Liu Y., Ng E.H.Y., Ho P.C., Yeung W.S.B. and Lee C.K.F., Differential gene expression of olfactomedin throughout the menstrual cycle is regulated by ovarian hormones., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.508.

 

Researcher : Ng TY



Project Title:

A propective randomised controlled trial: prevention of lymphedema by omentoplasty after pelvic lymphadenectomy

Investigator(s):

Ng TY, Ngan HYS

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Low Budget High Impact Programme

Start Date:

11/2001

 

Abstract:

To see whether these preliminary results are validated in a prospective randomised comparison.

 

Project Title:

A prospective randomized controlled trial: prevention of Lymphedema by Omentoplasty after pelvic lymphadenectomy

Investigator(s):

Ng TY, Ngan HYS, Chan YM, Tam KF

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Health and Health Services Research Fund - Full Grants

Start Date:

04/2004

 

Abstract:

Lymphedema is a debilitating condition that occurs in up to 40% of patients after pelvic lymphadenectomy. New surgical techniques have been advocated to reduce this complication. A pilot study using Omentoplasty observed that 8% of patients after this procedure had clinical lymphedema compared with 40% in historical controls. This study aims to see whether these preliminary results are validated in a prospective randomised comparison.

 

 

Researcher : Ngai CSW



Project Title:

Vaginal misoprostol for first trimester termination of pregnancy prior to 9 weeks of gestation

Investigator(s):

Ngai CSW, Tang FOS, Chan YM, Ho PC

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Health Services Research Fund - Full Grants

Start Date:

05/1999

 

Abstract:

To compare the effectiveness of vaginal misoprostol (water vs no water added) in first trimester termination of pregnancy.

 

Project Title:

Cervical assessment in prediction of preterm labour: is three-dimensional ultrasonography a better choice?

Investigator(s):

Ngai CSW, Lao TTH, Chen M, Leung KY

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2003

 

Abstract:

To compare the usefulness of 3D versus 2D US in prediction of preterm labour.

 

Project Title:

Multiple pregnancy and gestational diabetes: a physiological response or a pathologic condition?

Investigator(s):

Ngai CSW, Lao TTH, Leung WC

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2004

 

Abstract:

To investigate the incidence of gestational disbetes mellitus in twin pregnancy; to investigate the changes of glucose metabolism throughout pregnancy in multiple pregnancy; to evaluate the diagnostic criteria of gestational diabetes mellitus in twin pregnancy.

 

 

Researcher : Ngan ESW



Project Title:

Novel Function(s) of Prokineticins in Neural Crest Stem Cells

Investigator(s):

Ngan ESW, Lui VCH, Tam PKH

Department:

Surgery

Source(s) of Funding:

Seed Funding Programme for Basic Research

Start Date:

01/2006

 

Abstract:

The mammalian enteric nervous system (ENS) is derived from the neural crest cells (NCC) which enter the foregut and colonize the entire wall of gastrointestinal tract (1). In mice, NCCs reach foregut at approximately embryonic day 9.4 (E9.5) and finish the colonization by ~E14.5. Numerous gut mesenchyme/mucosa-derived factors and their receptors on NCC are found to be crucial for NCC proliferation, differentiation and migration. They are glial cell-line derived neurotrophic factor (GDNF) and its receptors (RET, GFRA1)(2); endothelin 3 (EDN3) and its receptor (EDNRB)(3); sonic hedgehog (Shh) and its receptor (Ptc)(4). A delicate balance between these signals is a prerequisite for the proper regulation of NCCs during ENS development. Failure to completely colonize the gut results in the absence of enteric ganglia as seen in Hirschsprung’s disease in human.. Prokineticin –1 and -2 (Prok-1 and Prok-2), also referred to endocrine gland derived vascular endothelial growth factor (EG-VEGF) and Bv8, respectively, are structurally related and belong to a newly identified family of secreted proteins, AVIT protein family. These proteins are distributed widely in mammalian tissues. Prok-1 mRNA expression has been described in a variety of tissues, in steroidogenic glands such as the ovary, testis, adrenal gland and placenta, but also in the brain, colon, skeletal muscle, small intestine, spleen, thymus liver, bladder, prostate and uterus(5,6) . Prok-2, on the other hand, shows the highest expression in testis, colon, brain and peripheral blood leukocytes(7,8). These two prokineticins are known to bind to two closely related G protein-coupled receptors, PK-R1 and PK-R2. Receptor activation leads to mobilization of calcium, stimulation of phosphoinositide turnover, and activation of p44/p42 MAPK signaling pathways. Within distinct contexts, the receptors are likely differentially regulated and distinct expression patterns of Prok receptors were observed in various tissues. In the adrenal gland, only PK-R1 was detected. In the ovary, follicular cells predominantly express PK-R1, whereas corpus luteum-derived cells express high levels of both PK-R1 and PK-R2. Similarly, these two receptors are also co-existing in endometrium, but at different expression level. Therefore, it is believed that prokineticins may have different angiogenic as well as non-angiogenic functions in different tissues via acting on either PK-R1 or PK-R2. However, the exact role(s) of PK-R1 and PK-R2 remains unclear. A new appreciation for the intricacy of peptidergic GPCRs is developing, as the ligands for orphan receptors are identified and as distinct signaling and functional responses for multiple ligands and oligomerized receptors are demonstrated. Thus, the distinct or overlapping expression of prokineticins and the possible heteroligomerization of receptors may increase the functional complexity of this system (8,9). It is currently known that prokineticins possess diverse biological functions: they promote angiogenesis in ovary and testis; induce proliferation, migration and fenestration of endothelial cells derived from adrenal gland ; support neuronal survival; cause hyperalgesia of skin; promote contraction of gastrointestinal smooth muscle; and control pain sensation and behavioral circadian rhythms(8,9). More recently, these two receptors were also found in human and mouse hematopoietic stem cells and specific mature blood cells, including lymphocytes. Prokineticins can modulate growth, survival, and function of cells of the innate and adaptive immune systems, possibly through autocrine or paracrine signaling mechanisms(7). Given the reported expression patterns and activities of the mammalian orthologs in brain, reproductive tract, and cells of the immune system, the molecules seem to have subserved similar functions across evolution. In addition to being the angiogenic factors, prokineticins would be the universal survival/mitogenic factors for various cells including endothelial cells, neuronal cells, lymphocytes as well as the hematopietic stem cells. Noteworthy, prokineticins and their receptors were detected in mouse embryo as early at E7, the role(s) of these factors during embryonic development still remains to be disclosed. Our preliminary data: It is known that prokineticin-1 is expressed in mouse and human small intestine and colon. Using antibody specific to Prok-1 to perform the immunohistochemistry study, we found that Prok-1 protein is expressed in the mucosa and enteric neuronal plexus of the gut in the adult mouse. The presence of Prok-1 in neuronal plexus was subsequently confirmed by colocalization study with the neuronal marker, Tuj1 (Appendix I, Figure 1g-i). In embryonic stage, it is highly expressed in the mucosa (E12.5 and E15.5) and forms a concentration gradient across the radius of the embryonic gut (Appendix I, Figure 1a-f). Subsequent RT-PCR analysis also showed that NCCs do not express endogenous Prok-1 (data not shown). A physiological effect of Prok-1 is dependent on the presence of the ligand and the receptor, so we have also examined the expression of the receptors, PK-R1 and PK-R2. Expression study using RT-PCR showed that the PK-R1, but not PK-R2, is expressed in NCCs isolated from E11.5 embryonic gut (Appendix I, Figure 2A). Localization of PK-R1 receptor using in situ hybridization further demonstrated the existence of PK-R1 in the NCCs and NCC derived enteric neurons of the embryonic guts (E10.5-E17.5). The signal is specific because there is no fluorescent signal detected when sense probe was used (Ctrl, Appendix I, Figure 2B). Taken together, it is believed that Prok-1, probably like GDNF, EDN3 and Shh, acts as mesenchyme/mucosa-derived factors and mediate the proliferation or differentiation of NCCs during ENS development. On the other hand, it may also act as a survival factor for the enteric neurons in the adult gut, via an autocrine/paracrine mechanism. Thus, we hypothesize that Prok-1 provides an additional layer of signaling refinement to maintain survival/proliferation of NCCs and mature neurons of the developing and mature ENS, respectively. The aim of this proposed project is to elucidate the physiological role(s) of prokineticins in ENS and during its development. Objective 1: To study the temporal and spatial expression patterns of prokineticins (Prok-1 and Prok-2) and their receptors in mouse gut during ENS development. The information obtained would give a hint to delineate the potential physiological functions of these molecules. Objective 2: To elucidate the mitogenic/neuroprotective properties of prokineticins on NCCs and NCC derived neurons. The functions of prokineticins in NCCs will be examined directly using the in vitro NCC culture system. Objective 3: To examine the effect of prokineticins on the differentiation capacity of NCCs. Reference 1. D. Newgreen, H. M. Young, Pediatr. Dev. Pathol. 5, 329 (2002). 2. A. Barlow, E. de Graaff, V. Pachnis, Neuron 40, 905 (2003). 3. G. M. Kruger et al., Neuron 40, 917 (2003). 4. M. Fu, V. C. Lui, M. H. Sham, V. Pachnis, P. K. Tam, J. Cell Biol. 166, 673 (2004). 5. J. LeCouter et al., Nature 412, 877 (2001). 6. E. S .Ngan et al., Endocrinology Oct 6; [Epub ahead of print] (2005) . 7. J. LeCouter, C. Zlot, M. Tejada, F. Peale, N. Ferrara, Proc. Natl. Acad. Sci. U. S. A 101, 16813 (2004). 8. A. Kaser, et al., EMBO reports 4,469 (2003) 9. J. LeCouter, R. Lin, N. Ferrara Ann. N.Y. Acad. Sci 1014: 50(2004).

 

Project Title:

Is thyroid transcription factor (TTF-1) the susceptibility gene for familial papillary thyroid carcinoma (PTC) predisposition

Investigator(s):

Ngan ESW, Garcia-Barcelo MM, Tam PKH, Lo CY, Khoo US

Department:

Surgery

Source(s) of Funding:

Seed Funding Programme for Basic Research

Start Date:

03/2007

 

Abstract:

Papillary thyroid carcinoma (PTC) is the most common malignant thyroid carcinoma, comprising an estimated 80% of thyroid cancers. Somatic genetic alterations in PTC, including RET/PTC rearrangements(1-4) and BRAF(5) and RAS(6) mutations have proved useful as prognostic markers and may represent the result to a cancer initiation process governed by the constitutive DNA endowment of the patient. Nevertheless, these genetic alterations only account for approximately 70% of PTC and the correlations with clinicopathological features of increase morbidity are still inconclusive. Importantly, 3.5-6.2% of PTC patients have one or more first-degree relatives with thyroid carcinoma, suggesting the presence of heritable genetic determinants for PTC predisposition, but the genetic basis of familial PTC is yet unknown. Thyroid transcription factor-1 (TTF-1) is a key player implicated in the thyroid development and associated disorders. TTF-1 knockout mice present with a series of congenital defects including lack of thyroid(7). Heterozygous "de novo" TTF1 mutations inherited in an autosomal dominant manner are associated with compensated congenital hypothyroidism(8-10). Regarding tumorigenesis, it is known to be a differentiation marker and inversely related to the malignant phenotype of thyroid neoplasms. More recently, it has been demonstrated that conditional ablation of TTF-1 in adult thyroid results in formation of adenomas and extremely high serum TSH levels(11). In an attempt to identify all possible risk-conferring variations (germ-line mutation) on TTF1 associated with PTC, we have performed a pilot genetic screening on ninety-five PTC patients. We have identified four novel germ-line mutations in exon-2 of TTF-1 in 7% of PTC patients. Importantly, these germ-line mutations have potentially significant implication on familial PTC predisposition. Therefore, we propose to study:Objective 1: Implication of TTF-1 germ-line mutations in families segregating the disease. A) The prevalence and predisposition of these germ-line mutations in the patients and their family will be determined. It will be the first identification of heritable genetic determinant for PTC predisposition. B) A complete profile on the somatic genetic alterations in patients bearing TTF-1 mutations will be established. Potential genetic interactions of these candidate genes with TTF-1 may account for the different penetrance of the mutations.Objective 2: Underlying molecular mechanisms for PTC conveyed by the TTF-1 germ-line mutations. A) Functional characterization of the mutant proteins. Impacts of the mutations on transactivation activity of TTF-1 will be demonstrated.B) Biological implications of the mutants in tumorigenesis. It provides the direct evidence on the role of mutants in tumorigenesis and facilitates the establishment of genotype-phenotype correlation.Reference:1.Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP, et al. 1995 Cancer research 55:5617-56202.Ito T, Seyama T, Iwamoto KS, Mizuno T, Tronko ND, Komissarenko IV, Cherstovoy ED, Satow Y, Takeichi N, Dohi K, et al. 1994 Lancet 344:2593.Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM 1995 Oncogene 11:2459-24674.Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N, et al. 1992 The Journal of clinical investigation 89:1517-15225.Xing M 2005 Endocrine-related cancer 12:245-2626.De Vita G, Bauer L, da Costa VM, De Felice M, Baratta MG, De Menna M, Di Lauro R 2005 Molecular endocrinology 19:76-897.Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ 1996 Genes & development 10:60-698.Devriendt K, Vanhole C, Matthijs G, de Zegher F 1998 The New England journal of medicine 338:1317-13189.Doyle DA, Gonzalez I, Thomas B, Scavina M 2004 The Journal of pediatrics 145:190-19310.Iwatani N, Mabe H, Devriendt K, Kodama M, Miike T 2000 The Journal of pediatrics 137:272-27611.Kusakabe T, Kawaguchi A, Hoshi N, Kawaguchi R, Hoshi S, Kimura S 2006 Molecular endocrinology 20:1796-1809.

 

 

Researcher : Ngan HYS



Project Title:

High dose cis-platinum and cyclophosphamide vs taxol in ovarian cancer

Investigator(s):

Ngan HYS, Wong RLC

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Other Funding Scheme

Start Date:

07/1994

 

Abstract:

To study high dose cis-platinum and cyclophosphamide vs taxol in ovarian cancer.

 

Project Title:

Rapid identification of tumour-specific gene methylation at multiple loci in gynaecological cancers

Investigator(s):

Ngan HYS, Liu VWS

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2004

 

Abstract:

To determine and differentiate the methylation status for 30 gene loci among the three gynaecological cancers using a pooled DNA approach.

 

Project Title:

Study of human papillomavirus status in Southern Chinese women with normal cervix, precancerous cervical lesions and cervical cancers

Investigator(s):

Ngan HYS, Cheung ANY, Chan YK, Fong DYT, Lin ZQ

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Research Fund for the Control of Infectious Diseases - Full Grants

Start Date:

10/2006

 

Abstract:

This cross-sectional study will investigate the current spectrum and prevalence of HPV circulating among healthy females in Guangdong and Hong Kong. The integration of the high risk HPVs in relation to precancerous cervical lesion and cervical cancer in both regions will be assessed with epidemiological data. The data yielded will be compared between these two regions.

 

Project Title:

Potential interaction between Zic2 and Gli proteins in enhancing the oncogenic role of hedgehog signaling in cervical cancer

Investigator(s):

Ngan HYS, Chan DW, Liu VWS

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Seed Funding Programme for Basic Research

Start Date:

03/2007

 

Abstract:

PURPOSE OF PROPOSED INVESTIGATION The purpose is to investigate the roles of Hedgehog signaling in the development of cervical cancer, and functionally characterize whether Zic2, one of the zinc finger proteins, synergistically enhances the oncogenic role of hedgehog signaling in cervical cancer . HYPOTHESISCervical cancer, a potentially preventable disease, remains the second most common malignancy in women worldwide. Human papillomavirus (HPV) is the single most important etiological agent in cervical cancer, contributing to neoplastic progression through the action of viral oncoproteins, mainly E6 and E7, which interfere with critical cell cycle pathways, p53 and retinoblastoma, respectively. However, evidence suggests that human papillomavirus infection alone is insufficient to induce malignant changes. Therefore, the transformation from low-grade lesion to invasive cancer must involve other cellular genetic changes affecting oncogenes, tumour suppressor genes or signal transduction pathway. Hedgehog signaling pathway and cervical cancerThe Hedgehog signaling pathway (HHS) was identified two decades ago in Drosophila as a critical regulatory mechanism of cell-fate determination during embryogenesis (Nusslein-Volhard C, Wieschaus E, 1980). In mammals there are three Hh-family proteins: Sonic (Shh), Indian (Ihh), and Desert (Dhh). Gene-targeting experiments in mice have demonstrated that the development and patterning of essentially every major organ requires input from the Hh pathway (Ingham PW and McMahon AP, 2001). The Hh-signaling pathway comprises three main components: the Hh ligand; a transmembrane receptor circuit composed of the negative regulator Patched (PTCH) plus an activator, Smoothened (Smo); and finally a cytoplasmic complex that regulates the Cubitus interruptus (Ci) or Gli family of transcriptional effectors which include Gli1, Gli2, and Gli3. Aberrant activation of the HHS pathway has been documented in promoting cell poroliferation, tumor growth and metastasis in skin (Couve-Privat et al., 2004; Cui et al., 2004; Athar et al., 2006), prostate (Fan et al., 2004; Sanchez et al., 2004; Karhadkar et al., 2004) and hepatocellular carcinomas (Huang et al., 2006). This indicates the significant role of HHS in cancer development. However, the roles of HHS in cervial cancer remains unknown. However, a recent report has shown that the expression levels of Gli1, Gli2 and Gli3 in Hedgehog signaling pathway is elevated in uterine cervical tumors, including carcinoma and its precursor lesions (Xuan et al., 2006). The expression of those molecules is significantly increased in cervical intraepithelial neoplasia (CIN) and carcinoma, compared with that in normal epithelium (Xuan et al., 2006). Importantly, the expression of Shh is increased by double; the first increase occurred in normal epithelium-CIN transition and the second, during the progression of CIN to carcinoma (Xuan et al., 2006). These results strongly suggest that the Hedgehog signaling pathway was extensively activated in carcinoma and CIN of uterine cervix. Zic2 and Hedgehog signaling pathwaing in cervical cancerZic family genes encode zinc finger proteins Zic1, Zic2 and Zic3, which play important roles in vertabrate development (Grinberg and Millen, 2005). The zinc finger domains are highly conserved between Zic proteins and show a notable homology to those of Gli family proteins. Zic and Gli were found to collaborate with each other in neural and skeletal development (Aruga, 2004). It was shown that there is physical interaction between Gli and Zic proteins via their zinc finger domains (Koyabu et al., 2001). Gli and Zic proteins also control gene transcriptional activity and subcellular localization of each other (Koyabu et al., 2001). In different cell types, coexpresssion of Gli and Zic in cultured cells mutually suppress or synergistically enhance gene transcription (Mizugishi et al., 2001). This suggests that there is a significant regulatory relationship between Gli and Zic proteins but the nature of this interaction may be modulated by cell type-specific cofactors. In addition, coexpressed Zic proteins translocate Gli proteins to the cell nuclei. Therefore Zic proteins are potential modulator of Hedgehog signaling pathway. So Zic proteins may play an important regulatory role in tumor progression.PROJECT OBJECTIVESThe aims of the proposed work are to fully characterize Zic2, its roles on Hedgehog signaling pathway, and the functions of this pathway on tumorigenesis in cervical cancer as follows:(1) To investigate the expression of molecules of the HHS pathway in cervical tumours by RT-PCR and immunohistochemical staining.(2) To exaimine the roles of HHS pathway in tumroigenicity of cervical cancer.(3) To investigate the interaction between Zic and Gli proteins in cervical cancer cells.(4) To investigate the roles of Zic2 in modulating HHS pathway and tumroigenicity of cervical cancer.KEY ISSUES AND PROBLEMS BEING ADDRESSEDThrough advances in diagnosis and treatment, cervical cancer has became a potentially preventable disease. However, cervical cancer is still the fifth most common cancer among women and is the number 11 cancer killer among women in Hong Kong, accounting for 106 deaths in 2003 (Hong Kong Cancer Registry, Hospital Authority, 2003). Understanding the roles of Zic2 and HHS pathway would give a better insight into the development and tumor progression of cervical cancer. This would provide a scientific basis for future development of novel treatment options.

 

List of Research Outputs

 

Chan D.W., Lee Y.W., Liu V.W.S. and Ngan H.Y.S., Overexpression of AMPKgamma 2 enhances tumorigenicity of Ovarian Cancer Cells, Annual Meetings of American Association for Cancer Research, April 12-16, 2008, San Diego, CA, USA. 2008.

 

Chan H.Y., Siu K.Y., Wong E.S.Y., Zhang H., Ngan H.Y.S. and Cheung A.N.Y., Expression of phospho-Stat3 in hydatidiform mole, 14th Hong Kong International Cancer Congress, 14-16 Nov. 2007.

 

Chan H.Y., Siu K.Y., Wong E.S.Y., Zhang H., Ngan H.Y.S. and Cheung A.N.Y., Expression of phospho-Stat3 in hydatidiform mole, 14th Hong Kong International Cancer Congress, Hong Kong, 14-16 November. 2007.

 

Chan K.K.L., Ip P.P.C., Kwong P.W.K., Tam K.F. and Ngan H.Y.S., A combination of chemoirradiation and chemotherapy for treatment of advanced clear cell adenocarcinoma of the cervix (p 559-563) , In: John J. Kavanagh and Uziel Beller, International Journal of Gynecological Cancer. Wiley interscience, 2008, 18: 559-563.

 

Chan K.K.L., Wei N., Liu S., Liao X., Cheung A.N.Y. and Ngan H.Y.S., Estrogen receptor subtypes in ovarian cancer: a clinical correlation, Obstet Gynecol. 2008, 111: 144-151.

 

Chan K.K.L., Tam K.F., Tse K.Y. and Ngan H.Y.S., The role of physical examination in the routine follow up of patients treated for ovarian carcinoma, British Gynaecological Society Annual Conference 2007.

 

Chan K.K.L., Tam K.F., Tse K.Y. and Ngan H.Y.S., The use of vaginal antimicrobial after large loop excision of transformation zone: a prospective randomised trial, British Journal of Obstetrics and Gynaecology. 2007, 114(8): 970-976.

 

Chan Y.K., Ching C.Y.J., Xu M.S., Cheung A.N.Y., Yip S.P., Lam L.Y.C., Lai S.T., Chu C.M., Wong A.T.Y., Song Y., Huang F., Liu W., Chung P.H., Leung G.M., Chow E.Y.D., Chan E.Y.T., Chan J.C.K., Ngan H.Y.S., Tam P.K.H., Chan L.C., Sham P.C., Chan V.S.F., Peiris J.S.M., Lin S.C.L. and Khoo U.S., Association of ICAM3 Genetic Variant with Severe Acute Respiratory Syndrome, The Journal of Infectious Diseases. 2007, 196: 271-280.

 

Cheung A.N.Y., Tsun O.K.L., Szeto E.F., Wong G., Lo S. and Ngan H.Y.S., Application of Novel Markers to Cervial Cytology for enhancing Cervical Cancer Screening, Annual Scientific Meeting of Hong Kong Society of Cytology, Hong Kong, 8-9 December. 2007.

 

Feng H., Tsao G.S.W., Ngan H.Y.S., Xue W., Kwan H.S., Siu K.Y., Liao X., Wong E.S.Y. and Cheung A.N.Y., Over-expression of Prostatic Stem Cell Antigen (PSCA) is associated with Gestational Trophoblastic neoplasia. , Histopathology. 2007, 52: 167-174.

 

Feng H., Tsao G.S.W., Ngan H.Y.S., Xue W., Kwan H.S., Siu K.Y., Liao X., Wong E.S.Y. and Cheung A.N.Y., Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia, Histopathology. 2008, 52(2): 167-174.

 

Hui P.W. and Ngan H.Y.S., Discipline-based examination and generic assessment principles, 5th Asia Pacific Medical Education Conference (APMEC), 24-27 January, 2008, Singapore. 2008.

 

Kwan T.T.C., Chan K.K.L., Yip M.W., Tam K.F., Cheung A.N.Y., Young P.M.C., Lee P.W.H. and Ngan H.Y.S., Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative–quantitative study, Sex Transm Infect. 2008, 84(3): 227-232.

 

Leung C.Y., Liu S., Chan Y.K., Tam K.F., Chan K.K.L., Wong R.L.C. and Ngan H.Y.S., Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer, Oncology Reports. 2008, 19: 1339-1345.

 

Li A.S.M., Siu K.Y., Wong E.S.Y., Chan Y.K., Ngan H.Y.S. and Cheung A.N.Y., Effect of demethylation and histone deacetylase inhibitors on the expression of stem cell related genes in choriocarcinoma cell lines, 14th Hong Kong International Cancer Congress, Hong Kong, 14-16 November. 2007.

 

Liao X., Siu K.Y., Au W.H., Wong E.S.Y., Ngan H.Y.S. and Cheung A.N.Y., Aberrant Activation of Hedgehog Signaling Pathway in Ovarian Cancer, 99th American Association for Cancer Research 2008 Annual Meeting, San Diego, 12-16 April. 2008.

 

Liu S., Tsang P.C.K., Chan Y.K., Cheung A.N.Y., Chan K.K.L., Leung C.Y. and Ngan H.Y.S., Distribution of Six Oncogenic Types of Human Papillomavirus and Type 16 Integration Analysis in Chinese Women with Cervical Precancerous Lesions and Carcinomas, Tumour Biol. 2008, 29(2): 105-113.

 

Liu V.W.S., Chan D.W., To M.Y., Chiu C.N. and Ngan H.Y.S., Forkhead box transcription factor FoxG1 is over-expressed in ovarian cancer and can inhibit p21 expression, Annual Meeting of the American Association for Cancer Research, April 12-16, 2008, San Diego, U.S.A.. 2008.

 

Ngan H.Y.S., "Can we reduce anxiety during colposcopy?" and "HPV genotyping meta-analysis", XXth Scientific Meeting, Australian Society for Colposcopy and Cervical Pathology (ASCCP), Gold Coast, Australia, 27-30 September, 2007. 2007.

 

Ngan H.Y.S., Cervical cancer vaccine-your questions answered, Hong Kong Academy of Medicine (HKAM) CME , July 12, 2007, Hong Kong . 2007.

 

Ngan H.Y.S., Co-Chairman and Faculty in the MSD session, 24th International Papillomavirus Conference in Beijing, China, November 5, 2007, MSD sponsored session. 2007.

 

Ngan H.Y.S., Co-eiitor : Staging classification and gynecologic cancers, FIGO Gynecologic Oncology and IGCS Guidelines Committee, Third Edition, November 2006. 2007.

 

Ngan H.Y.S., Comparison of HPV infection between Hong Kong and Guangzhou, The First China Hybribio HPV Conference, Shenzhen, China, June 14, 2008. 2008.

 

Ngan H.Y.S., Editorial Boaed Member - Journal of Paediatrics, Gynaecology and Obstetrics 1997. 2007.

 

Ngan H.Y.S., Editorial Board Member - Gynecologic Oncology 2005. 2007.

 

Ngan H.Y.S., Editorial Board Member - Hong Kong Journal of Gynaecology, Obstetrics and Midwifery 1998. 2007.

 

Ngan H.Y.S., Editorial Board Member - International Journal of Gynecologic Cancer 2001. 2007.

 

Ngan H.Y.S., Editorial Board Member - Journal of Clinical Oncology (Chinese Edition) 2000. 2007.

 

Ngan H.Y.S., Editorial Board Member - Journal of Obstetrics and Gynaecology Research 1997. 2007.

 

Ngan H.Y.S., Editorial Board Member - The Hong Kong Medical Journal. 2007.

 

Ngan H.Y.S., Editorial Board Member of 实用婦產科雜誌(編 委) 2008. 2008.

 

Ngan H.Y.S., Guest Editor of a book "Clinical Obstetrics and Gynaecology (Bailliere's Best Practice and Research) on "Gestational Trophoblastic Diseases" 2003. 2007.

 

Ngan H.Y.S., HPV and cervical cancer prevention, Hong Kong Women Doctors Association, Annual General Meeting, December 10, 2007. 2007.

 

Ngan H.Y.S., HPV and cervical cancer, 2nd Reproductive Health Conference, Macau Society of Obstetrics and Gynaecology, Macau, March 29, 2008 . 2008.

 

Ngan H.Y.S., HPV testing - reappraisal, Forum on HPV testing organized by the Singapore Cancer Society and AOFOG, May 3, 2008. 2008.

 

Ngan H.Y.S., HPV: an evasive pathogen and the need for broad and sustained protection, Seminars in HPV vaccinology: Jointly organized by The Taiwan Association of Gynecologic Oncologists and the Taiwan Pediatric Association, March 1-2, 2008. 2008.

 

Ngan H.Y.S., Head start on cervical cancer prevention, CME Session "Asian Perspectives to Clinical Pediatrics", Macau, July 8, 2007 by Excerpta Medica, Elsevier, Singapore. 2007.

 

Ngan H.Y.S., Tsang P.C.K., Chan Y.K., Liu S., Cheung A.N.Y., Chan K.K.L. and Leung C.Y., Human papillomavirus genotyping and integration in cervical cancers and precursor lesions, 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November. 2007.

 

Ngan H.Y.S., Kwan T.T.C., Tam K.F., Chan K.K.L., Young P.M., Lo S.S., Cheung A.N.Y. and Lee P.W.H., Knowledge and attitute of Chinese women on cervical cancer and human papillomavirus, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, September 21-25, 2007, Tokyo, Japan. 2007.

 

Ngan H.Y.S., Psychosocial burden of HPV-related diseases in 3 countries, Health Outcome modeling and HPV vaccines meeting hosted by Family Health International and Chulalongkorn University, Bangkok, Thailand, February 12, 2008 . 2008.

 

Ngan H.Y.S., Public awareness and psychosocial aspects of HPV vaccination, The Third Biennial Conference of Asia Oceania Research organization on Genital Infections and Neoplasia (AOGIN), Seoul, Korea, May 29-31, 2008. 2008.

 

Ngan H.Y.S., Liu S., Leung T.W., Cheung A.N.Y. and Chan Y.K., Study of human papillomavirus status in Southern Chinese women with normal cervix, precancerous cervical lesions and cervical cancers. , Health Research Symposium 2007: Building Bridges between research, practice and policy. September, Hong Kong. 2007.

 

Ngan H.Y.S., Surgical training in Hong Kong, 2007 Annual Scientific Meeting, The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Queensland, Australia, October 2-5, 2007. 2007.

 

Ngan H.Y.S., The role of PET scan in Gynaecological oncology, HKCOG Postgraduate Seminar, April 27, 2008. 2008.

 

Ngan H.Y.S., Updates on HPV prevention and vaccine, Joint Meeting HKSCCP and HKCFP, August 25, 2007, Hong Kong. 2007.

 

Pon Y.L., Zhou H., Cheung A.N.Y., Ngan H.Y.S. and Wong A.S.T., p70 S6 kinase promotes epithelial to mesenchymal transition through Snail induction in ovarian cancer cells, Cancer Research. 2008, 68(16): 6524-6532.

 

Siu K.Y., Chan H.Y., Kong S.H., Chan K.Y.Q., Ngan H.Y.S. and Cheung A.N.Y., Differential expression of folate receptor alpha and reduced folate carrier and effect of folate in ovarian cancer, 99th American Association for Cancer Research 2008 Annual Meeting, San Diego, 12-16 April. 2008.

 

Siu K.Y., Woo N.W., Wong E.S.Y., Chan H.Y., Chan K.Y.Q., Ngan H.Y.S., Tsao G.S.W. and Cheung A.N.Y., p21-activated kinase 4 in Ovarian Cancer: Its expression, localization and possible functional role, 16th Annual Growth Factor and Signal Transduction Symposium titled "Senescence, Aging and Cancer",Iowa, 26-29 July . 2007.

 

Tse K.Y., Chan K.K.L., Tam K.F. and Ngan H.Y.S., Current concepts in the management of endometrial carcinoma, Journal of Paediatrics, Obstetrics and Gynaecology. 2007, SEP/OCT: 213-220.

 

Woo N.W.S., Wong E.S.Y., Chan H.Y., Chan K.Y.Q., Ngan H.Y.S., Tsao G.S.W. and Cheung A.N.Y., p21-activated kinase 4 in Ovarian Cancer: Its expression, localization and possible functional role, 16th annual Growth Factor and Signal Transduction Symposium, Iowa, 26-29 July. 2007.

 

Yip C.T., Chan D.W., Liu V.W.S. and Ngan H.Y.S., Zic2 synergistically enhances Hedgehog signaling pathway in cervical cancer., The 12th Research Postgraduate Symposium 2007, The University of Hong Kong, Hong Kong, 12 Dec. 2007.. 2007.

 

Yip C.T., Chan D.W., Liu V.W.S. and Ngan H.Y.S., Zic2 synergistically enhances Hedgehog signaling pathway in cervical cancer., The 99th Annual Meeting of American Association of Cancer Research, 12-16 April 2008, San Diego, CA, USA.. 2008.

 

Zhang H., Siu K.Y., Li A.S.M., Chan K.Y.Q., Ngan H.Y.S. and Cheung A.N.Y., Oct-4 gene is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease, 14th Hong Kong International Cancer Congress, Hong Kong, 14-16 November. 2007.

 

Zhang H., Siu K.Y., Wong E.S.Y., Wong K.Y., Li A.S.M., Chan Y.K., Ngan H.Y.S. and Cheung A.N.Y., Oct4 is Epigenetically Regulated by Methylation in Normal Placenta and Gestational Trophoblastic Disease, Placenta. 2008, 29(6): 549-554.

 

Researcher : Ong CYT



Project Title:

To determine the correlation of changes in maternal levels of pregnancy-associated plasma protein A (PAPP-A) and free [beta] human chorionic gonadotrophin (F[beta]-hCG) with placental development and fetal outcomes

Investigator(s):

Ong CYT, Lao TTH, Leung WC, Leung KY, Lam HSW

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2003

 

Abstract:

To correlate the serial changes of maternal serum PAPP-A and free [beta]-hCG concentrations with placental volume and vascular indices, swell as fetal size, as assessed by 3-D/4-D ultrasonographic studies throughout pregnancy; to determine whether different patterns in the changes of PAPP-A and free [beta]-hCG in different trimesters will be predictive of different patterns of placental development and fetal growth, and whether this can help to identify specifically the eventual complications through the association with the various growth and developmental patterns.

 

 

Project Title:

First trimester prediction of fetal α-thalassaemia-1 with maternal serum markers, nuchal translucency measurement and three dimentional ultrasound measurement of placental volume

Investigator(s):

Ong CYT, Chen M, Leung KY, Tang MHY, Lee CP

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

11/2004

 

Abstract:

To measure 3D ultrasound placental and fetal volume at 10-14 weeks of gestation, and to determine whether different changes in the placental volume is predictive of fetuses affected by α-thalassaemia-1; to measure maternal serum PAPP-A and free β-hCG concentrations in fetuses affected and unaffected by β-thalassaemia-1 at 10-14 weeks of gestation, and determine the predictive value of these markers along with or without NT measurement in diagnosis of fetuses affected by α-thalassaemia-1.

 

Project Title:

Maternal serum level of ADAM 12 as an early marker of trisomy 21, trisomy 13 and trisomy 18

Investigator(s):

Ong CYT, Lee CP, Lau ETK

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

01/2007

 

Abstract:

Objectives 1. To investigate the use of maternal serum ADAM 12 concentration in the first trimeter as a marker of trisomy 21, trisomy 18 and trisomy 13. 2. To correlate maternal serum with pregnancy outcomes Brief background and significance The ADAMs (A disintegrin and metalloprotease) constitute a glycoprotein family with proteolytic and cell-adhesion activities (Wolfsberg et al., 1995; Primakoff and Myles, 2000; Seals and Courtneidge, 2003). Human ADAM12 exists in two forms, ADAM12-L (long) and ADAM12-S (short), the latter being the secreted form of ADAM12. ADAM12-S differs from ADAM12-L at the C-terminal end in that it does not contain the transmembrane and cytoplasmatic domains (Gilpin et al., 1998). ADAM12-S binds to and has proteolytic activity against insulin-like growth factor binding protein (IGFBP)-3 and, to a lesser extent, IGFBP-5. Insulin growth factors (IGFs) I and II are proinsulin-like polypeptides that are produced in nearly all foetal and adult tissues. Lack of IGF I and II causes foetal growth retardation in mice (Powel-Braxton et al., 1993). The cleavage of IGFBPs into smaller fragments with reduced affinity for the IGFs reverses the inhibitory effects of the IGFBPs on the mitogenic and DNA stimulatory effects of the IGFs (Blat et al., 1994). ADAM12-S is an important indicator of foetal growth because ADAM12-S is an IGFBP-3 protease and IGFBP-3 is the most abundant IGFBP in serum. The proteolysis of IGFBP-3 would stimulate growth by increasing levels of bioavailable IGF I and II. Previous study (Laigaard et al. 2003) has reported that in 18 first trimester Down syndrome pregnancies versus 136 healthy controls, maternal serum concentration of ADAM12 was decreased with the median multiple of mean (MoM) value of 0.14 (0.01-0.76). This results in a detection rate of 82% for a false positive rate of 3.2% (using 1:400 risk as cut-off) for fetal Down syndrome. In another study (Laigaard et al. 2005), maternal serum ADAM 12-S concentrations were found to be lower in trisomy 18 pregnancies than in normal pregnancies, with a median multiple of the median (MoM) of 0.28 (p < 0.001). These findings suggest that maternal serum ADAM 12-S may be a novel marker for trisomy 21, trisomy 18 and perhaps trisomy 13 in the first trimester of pregnancy. Pregnancy associated plasma protein-A (PAPP-A) and ADAM12-S are both IGFBP-5 proteases synthesised by the placenta. Low concentrations of maternal serum PAPP-A are associated with fetal trisomy 21 (Brambati et al. 1993, Macintosh et al. 1994, Spencer et al. 1999) and pregnancy adverse outcomes (Ong et al. 2000). Therefore ADAM12 can be a worthwhile marker for investigation as an indicator of foetal well-being. References: Blat C, Villaudy J, Binoux M. 1994. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93: 2286–2290. Brambati B, Macintosh MC, Teisner B, Maguiness S, Shrimanker K, Lanzani A, Bonacchi I, Tului L, Chard T, Grudzinskas JG 1993. Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol 100(4):324-6. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM. 1998. A novel secreted form of human ADAM12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 273: 157–166. Laigaard J, Christiansen M, Frohlich C, Pedersen BN, Ottesen B, Wewer UM 2005. The level of ADAM12-S in maternal serum is an early first-trimester marker of fetal trisomy 18. Prenat Diagn. 25(1):45-6. Laigaard J, Sorensen T, Frohlich C, Pedersen BN, Christiansen M, Schiott K, Uldbjerg N, Albrechtsen R, Clausen HV, Ottesen B, Wewer UM 2003. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 30;23(13):1086-91. Macintosh MC, Iles R, Teisner B, Sharma K, Chard T, Grudzinskas JG, Ward RH, Muller F 1994. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks. Prenat Diagn 14(3):203-8. Ong CYT, Liao AW, Spencer K, Munim S, Nicolaides KH 2000.First trimester maternal serum free human chorionic gonadotrophin & pregnancy associated plasma protein A as predictors of pregnancy complications. Br J Obstet Gynaecol 107: 1265-1270. Powel-Braxton L, Hollingshead P, Warburton C, et al. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev 7: 2609–2617. Primakoff P, Myles DG. 2000. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 16: 83–87. Seals DF, Courtneidge SA. 2003. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17: 7–30. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13(4):231-7. Wolfsberg TG, Primakoff P, Myles DG, White JM. 1995. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 131: 275–278.

 

 

Researcher : Pang RTK



List of Research Outputs

 

Chiu C.N., Wong S.T., Lee C.L., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Native human zona pellucida glycoproteins: purification and binding properties, Human Reproduction. 2008, 23: 1385.

 

Chiu C.N., Wong B.S., Lee C.L., Chung M.K., Lam K.K., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Purification of native human zona pellucida glycoproteins from eggs: Binding characteristics to human spermatozoa, hyper-activation, acrosomal exocytosis, and sperm-oocyte interaction. P.74, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Purification and identification of a glycodelin-C interacting protein from human cumulus matrix, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Lin S.S.W., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Microrna expression profile and their regulatory roles in ovarian folliculogenesis , Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Pang R.T.K., Liu W., Chiu C.N., Lee C.K.F. and Yeung W.S.B., Microrna regulates notch1 receptor in hela cells, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Researcher : Pun TC



List of Research Outputs

 

Ip P.P.C., Lam K.W., Cheung C.L., Yeung C.W., Pun T.C., Chan K.Y.Q. and Cheung A.N.Y., Tranexamic Acid-associated Necrosis and Intralesional Thrombosis of Uterine Leiomyomas: A Clinicopathologic Study of 147 Cases Emphasizing the Importance of Drug-induced Necrosis and Early Infarcts in Leiomyomas , American Journal of Surgical Pathology. 2007, 31(8): 1215-1224.

 

Researcher : Tam KF



List of Research Outputs

 

Chan K.K.L., Ip P.P.C., Kwong P.W.K., Tam K.F. and Ngan H.Y.S., A combination of chemoirradiation and chemotherapy for treatment of advanced clear cell adenocarcinoma of the cervix (p 559-563) , In: John J. Kavanagh and Uziel Beller, International Journal of Gynecological Cancer. Wiley interscience, 2008, 18: 559-563.

 

Chan K.K.L., Tam K.F., Tse K.Y. and Ngan H.Y.S., The role of physical examination in the routine follow up of patients treated for ovarian carcinoma, British Gynaecological Society Annual Conference 2007.

 

Kwan T.T.C., Chan K.K.L., Yip M.W., Tam K.F., Cheung A.N.Y., Young P.M.C., Lee P.W.H. and Ngan H.Y.S., Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative–quantitative study, Sex Transm Infect. 2008, 84(3): 227-232.

 

Leung C.Y., Liu S., Chan Y.K., Tam K.F., Chan K.K.L., Wong R.L.C. and Ngan H.Y.S., Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer, Oncology Reports. 2008, 19: 1339-1345.

 

Ngan H.Y.S., Kwan T.T.C., Tam K.F., Chan K.K.L., Young P.M., Lo S.S., Cheung A.N.Y. and Lee P.W.H., Knowledge and attitute of Chinese women on cervical cancer and human papillomavirus, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, September 21-25, 2007, Tokyo, Japan. 2007.

 

Tse K.Y., Chan K.K.L., Tam K.F. and Ngan H.Y.S., Current concepts in the management of endometrial carcinoma, Journal of Paediatrics, Obstetrics and Gynaecology. 2007, SEP/OCT: 213-220.

 

Researcher : Tam VCG



List of Research Outputs

 

Tam V.C.G., Chiu C.N., Koistinen R., Koistinen M., Seppala M., Ho P.C., Lee C.K.F. and Yeung W.S.B., Glycodelin-C receptor on human spermatozoa., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.459.

 

Researcher : Tam YT



List of Research Outputs

 

Lee C.K.F., Zuo Y., Tam Y.T., Tang A.Y.B. and Yeung W.S.B., The acrosome-expressing proteins VAD1.3/AEP1 and VAD1.2 interact with syntaxin and b-acting in vitro., The Hong Kong Society of Endocrinology, Metabolism and Reproduction Annual Scientific Meeting. 2007.

 

Yan Z., Tam Y.T., Cheah K.S.E., Yeung W.S.B. and Lee C.K.F., Functional characterization of VAD 1.3 /AEP 1 Gene in acrosome-formation and fertility, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Zuo Y., Tam Y.T., Yeung W.S.B. and Lee C.K.F., Functional characterization of VAD1.3/AEP1 gene in acrosome-formation and fertility. O2.15., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Researcher : Tang AWS



List of Research Outputs

 

Tang A.W.S., Surgical training from the registrars' perspective, 2007 Annual Scientific Meeting, The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Queensland, Australia, October 2-5, 2007.

 

Researcher : Tang AYB



List of Research Outputs

 

Lee C.K.F., Zuo Y., Tam B.Y., Tang A.Y.B. and Yeung W.S.B., Syntaxin and b-actin interact with acrosome-expressing protein VAD1.2/AEP2 in spermatogenesis. P.282, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.K.F., Zuo Y., Tam Y.T., Tang A.Y.B. and Yeung W.S.B., The acrosome-expressing proteins VAD1.3/AEP1 and VAD1.2 interact with syntaxin and b-acting in vitro., The Hong Kong Society of Endocrinology, Metabolism and Reproduction Annual Scientific Meeting. 2007.

 

Researcher : Tang FOS



Project Title:

A prospective randomized comparison of sublingual and vaginal misoprostol in termination of pregnancy in the second trimester

Investigator(s):

Tang FOS, Ho PC

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Other Funding Scheme

Start Date:

10/2000

 

Abstract:

To compare the efficacy of sublingual and vaginal misoprostol in termination of second trimester pregnancy.

 

List of Research Outputs

 

Faundes A., Fiala C., Tang F.O.S. and Velasco A., Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy, International Journal of Gynecology and Obstetrics. 2007, 99 (Supplement 2): S172-S177.

 

Fiala C., Gemzell-Danielsson K., Tang F.O.S. and von Hertzen H., Cervical priming with misoprostol prior to transcervical procedures, International Journal of Gynecology and Obstetrics. 2007, 99 (Supplement 2): S168-S171.

 

Ho P.C., Blumenthal P.D., Gemzell-Danielsson K., Gomez Ponce de Leon R., Mittal S. and Tang F.O.S., Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks, International Journal of Gynecology and Obstetrics. 2007, 99 (Supplement 2): S178-S181.

 

Ng E.H.Y., Chan C.C.W., Tang F.O.S. and Ho P.C., Comparison of 2-Dimensional, 3-Dimensional, and vascular ultrasonographic parameters for endometrial receptivity between 2 consecutive stimulated in vitro fertilization cycles, Journal of Ultrasound In Medicine. 2007, 26(7): 931-939.

 

Ng E.H.Y., Lau E.Y.L., Yeung W.S.B., Cheung T.M., Tang F.O.S. and Ho P.C., Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage, Fertility and Sterility. 2008, 89(5): 1147-1153.

 

Ng E.H.Y., Chan C.C.W., Tang F.O.S., Yeung W.S.B. and Ho P.C., The role of endometrial blood flow measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment, European Journal of Obstetrics and Gynecology and Reproductive Biology. 2007, 135: 8-16.

 

Tang F.O.S., Gemzell-Danielsson K. and Ho P.C., Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects, International Journal of Gynecology and Obstetrics. 2007, 99, Supplement 2: S160-S167.

 

Tang F.O.S., Vekemans M., Hertzen H. and Ho P.C., Termination of pregnancy in the first trimester with misoprostol alone, International Planned Parenthood Federation Medical Bulletin. 2008, 42(1): 3-4.

 

Researcher : Tang GWK



Project Title:

A cross sectional health care study of Chinese perimenopausal women in Hong Kong

Investigator(s):

Tang GWK

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Other Funding Scheme

Start Date:

01/1993

 

Abstract:

To study Chinese women in Hong Kong on: 1) their perception and understanding of the menopause; 2) their symptoms expressed and experienced before, during and after the menopause; 3) bone density in various age groups ranging from adolescence to postmenopause and to correlate such values with biophysical parameters and diet; 4) how best health care strategies can be planned based on the findings in the study so that women's needs are met most cost effectively.

 

Project Title:

Fracture incidence reduction and safety of TSE-424 (Bazedoxifene Acetate) compared to placebo and Raloxifene in osteoporotic postmenopausal women / Endomentrial Safety Substudy

Investigator(s):

Tang GWK

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Wyeth Austral PTY Ltd - General Award

Start Date:

02/2002

 

Abstract:

(A) This reduction in the circulating levels of oestrogen during menopause is associated with a number of changes, including osteoporosis. Osteoporosis is characterized by a loss of bone mass and micro architectural deteroration of bones tissue, with a consequent increase in bone fragility and susceptibility to bone fracture. (B) Bazedoxifene acetate is a selective oestrogen receptor modulator (SERM). It has been designed to exhibit the positive effects of an oestrogen agonist on the skeletal and cardiovascular systems, while acting as an antagonist on the uterus and the breast. SERMs have 2 principal indications in the clinic: the prevenetion and treatment of postmenopausal osteoporsis(raloxifene) and the prevention and treatment of breast cancer (tamoxifen), mainly in postmenopausal women. (C) Pre-clinical studies suggest that bazedoxifene acetate protects bone at a lower dose than currently marketed SERMs with no uterine agonist effect, a low potentional to induce flushes, and an improvement in the serum lipid profile. Pre-clinical data has also demonstrated that bazedoxifene acetate effectively suppress the proliferation of breast cancer cell lines, which suggests that it may exhibit antagonist activity on breast cell proliferation. (D) This is a multi-centre, double-blind, randomised, placebo and active comparator controlled phase 3 trial that will involve approximately four thousand patients. There will be about 180 sites participating in the study, which will be conducted globally. Of the four thousand patients recrutied into the study, 1000 patients will be recruited to one of the following four study groups: 1. bazedoxifence acetate 20mg, 2. bazedoxifence acetate 40mg, 3. raloxifece 60mg, 4. placebo.

 

Project Title:

Main Study (013-01)- A study to Evaluate the Efficacy of Quadrivalent HPV (Types 6,11,16 and 18) L1 Virus-Like Particle (VLP) Vaccine in Reducing the Incidence of HPV 6/11-, 16- and 18- Related CIN, and HPV 16 and 18-Related AIS and Cervical Cancer, and HPV 6/11-, 16-, and 18-Related External Genital Warts, VIN and VaIN, and HPV 16 and 18-Related Vulvar and Vaginal Cancer in 16- to 23- Year-Old Women -- The F.U.T.U.R.E. I Study (Females United to Unilaterally Reduce Endo/Ectocervical disease). Substudy (012-01)- Immunogenicity and Safety of Quadrivalent HPV (Types 6,11,16,18)L1 Virus-Like Particle (VLP) Vaccine in 16- to 23-Year-Old Women With an Immunogenicity Bridge Between the HPV 16 Component of the Qualdrivalent Vaccine and the Monovalent HPV 16 Vaccine Pilot Manufacturing Material - The F.U.T.U.R.E. I Study (Females United to Unilaterally Reduce Endo/Ectocervical Disease)

Investigator(s):

Tang GWK

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Merck, Sharp and Dohme (Asia) Ltd. - General Award

Start Date:

08/2002

 

Abstract:

To demonstrate that a 3-dose regimen of quadrivalent HPV (Types 6,11,16,18) L1 VLP vaccine is generally well tolerated; to demonstrate that quadrivalent HPV vaccine is generally well tolerated.

 

List of Research Outputs

 

Kung A.W.C., Lee K.K., Ho A.Y.Y., Tang G.W.K. and Luk K.D.K., Ten-Year Risk of Osteoporotic Fractures in Postmenopausal Chinese Women According to Clinical Risk Factors and BMD T Scores: A Prospective Study, Journal of Bone and Mineral Research. 2007, 22: 1080-7.

 

Tang G.W.K., Adolescence and Contraception: Problems in Adolescents, 1st Scientific Meeting of the Asian Pacific Council on Contraception, Shanghai, PRC. 8 November. 2007.

 

Tang G.W.K., Graduate Quality Accreditation : Graduate vs School Accrediation, 4th Congress of Asian Medical Education Association, Bangkok, Thailand. 23-27 October . 2007.

 

Tang G.W.K., Health Services Provision from the Perspective of the Academia, U21 Health Sciences Meeting, Hong Kong. September. 2007.

 

Tang G.W.K., Medical Education: An uphill battle or a matter of course?, Distinguished Lecture, Department of Surgery, The University of Hong Kong, Hong Kong. November . 2007.

 

Tang G.W.K., Professionalism - way to service quality, Allied Health (AH) Conference - "Challenges for Modern Allied Health Leaders", Hong Kong, January . 2008.

 

Tang G.W.K., Treatment of Menopause: From the perspective of Western Medicine, 3rd International Symposium on Healthy Aging, Hong Kong. March . 2008.

 

Tang G.W.K., Leung K.Y. and Chan C.C.W., Use of hormone therapy: POST-WHI ERA in Hong Kong, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, Tokyo, Japan September 21-25 . 2007.

 

Tay E.H., Garland S., Tang G.W.K., Nolan T., Huang L.M., Orloski L., Lu S. and Barr E., Clinical trial experience with prophylactic HPV 6/11/16/18 VLP vaccine in young women from the Asia-Pacific region, International Journal of Gynecology and Obstetrics. 2008, 102 (March): 275-283.

 

Researcher : Tang MHY



List of Research Outputs

 

Leung K.Y., Tang M.H.Y. and Lam Y.H., Prenatal 2D and 3D ultrasound prediction of homozygous alpha thalassemia, AOCOG 2007 Golden Jubilee of Federation, The XXth Asian and Oceanic Congress of Obstetrics and Gynaecology, September 21-25, 2007, Tokyo, Japan. 2007.

 

Leung K.Y., Cheong K.B., Tang M.H.Y. and Chan V.N.Y., Prenatal diagnosis of thalassemia, Journal of Paediatrics, Obstetrics & Gynaecology. 2008, 34: 37-42.

 

Leung W.C., Lau E.T.K., Lau W.L., Tang R., Wong S.F., Lau T.K., Tse K.T., Wong S.F., To W.W.K., Ng L.K.L., Lao T.T.H. and Tang M.H.Y., Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?, Hong Kong Medical Journal. 2008, 14(1): 6-13.

 

Ng P.P.Y., Tang M.H.Y., Lau E.T.K., Ng L.K.L., Ngan E.H.Y., Tam P.C., Yeung W.S.B. and Ho P.C., Chromosome anomalies and Y-microdeletions in subfertile men (Poster), The ACAG-HKSMG International Conference, Hong Kong, 11 June 2008.

 

Researcher : To MY



List of Research Outputs

 

Liu V.W.S., Chan D.W., To M.Y., Chiu C.N. and Ngan H.Y.S., Forkhead box transcription factor FoxG1 is over-expressed in ovarian cancer and can inhibit p21 expression, Annual Meeting of the American Association for Cancer Research, April 12-16, 2008, San Diego, U.S.A.. 2008.

 

Researcher : To WWK



List of Research Outputs

 

Leung W.C., Lau E.T.K., Lau W.L., Tang R., Wong S.F., Lau T.K., Tse K.T., Wong S.F., To W.W.K., Ng L.K.L., Lao T.T.H. and Tang M.H.Y., Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?, Hong Kong Medical Journal. 2008, 14(1): 6-13.

 

Researcher : Tsang PCK



List of Research Outputs

 

Liu S., Tsang P.C.K., Chan Y.K., Cheung A.N.Y., Chan K.K.L., Leung C.Y. and Ngan H.Y.S., Distribution of Six Oncogenic Types of Human Papillomavirus and Type 16 Integration Analysis in Chinese Women with Cervical Precancerous Lesions and Carcinomas, Tumour Biol. 2008, 29(2): 105-113.

 

Ngan H.Y.S., Tsang P.C.K., Chan Y.K., Liu S., Cheung A.N.Y., Chan K.K.L. and Leung C.Y., Human papillomavirus genotyping and integration in cervical cancers and precursor lesions, 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China, November. 2007.

 

Researcher : Tse KT



List of Research Outputs

 

Leung W.C., Lau E.T.K., Lau W.L., Tang R., Wong S.F., Lau T.K., Tse K.T., Wong S.F., To W.W.K., Ng L.K.L., Lao T.T.H. and Tang M.H.Y., Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?, Hong Kong Medical Journal. 2008, 14(1): 6-13.

 

Researcher : Tse KY



List of Research Outputs

 

Chan K.K.L., Tam K.F., Tse K.Y. and Ngan H.Y.S., The role of physical examination in the routine follow up of patients treated for ovarian carcinoma, British Gynaecological Society Annual Conference 2007.

 

Lao T.T.H., Chan C.P., Leung W.C., Ho L.F. and Tse K.Y., Maternal hepatitis B infection and gestational diabetes mellitus, Journal of Hepatology. 2007, 47(1): 46-50.

 

Tse K.Y., Chan K.K.L., Tam K.F. and Ngan H.Y.S., Current concepts in the management of endometrial carcinoma, Journal of Paediatrics, Obstetrics and Gynaecology. 2007, SEP/OCT: 213-220.

 

Researcher : Tse PK



List of Research Outputs

 

Tse P.K., Lee Y.L., Chow W.N., Luk J.M.C., Lee K.F. and Yeung W.S.B., Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b, Endocrinology. 2008, 149(3): 1268-1276.

 

Researcher : Wei N



List of Research Outputs

 

Chan K.K.L., Wei N., Liu S., Liao X., Cheung A.N.Y. and Ngan H.Y.S., Estrogen receptor subtypes in ovarian cancer: a clinical correlation, Obstet Gynecol. 2008, 111: 144-151.

 

Researcher : Wong BPC



List of Research Outputs

 

Lee C.K.F., Wong B.P.C., Lai K.Y. and Yeung W.S.B., Cloning and characterization of oviductal demilune cell and parotid protein (Dcpp) gene promoter., The 23rd Annual Meeting of the european Society of Human Reproduction and Embryology. 2007.

 

Lee C.K.F., Wong B.P.C., Lai K.Y. and Yeung W.S.B., Cloning and characterization of oviductal demilune cell and parotid protein (Dcpp) gene promoter, The 23rd Annual Meeting of the european Society of Human Reproduction and Embryology. 2007.

 

Researcher : Wong RLC



List of Research Outputs

 

Leung C.Y., Liu S., Chan Y.K., Tam K.F., Chan K.K.L., Wong R.L.C. and Ngan H.Y.S., Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer, Oncology Reports. 2008, 19: 1339-1345.

 

Researcher : Wong SF



List of Research Outputs

 

Leung W.C., Lau E.T.K., Lau W.L., Tang R., Wong S.F., Lau T.K., Tse K.T., Wong S.F., To W.W.K., Ng L.K.L., Lao T.T.H. and Tang M.H.Y., Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?, Hong Kong Medical Journal. 2008, 14(1): 6-13.

 

Researcher : Wong ST



List of Research Outputs

 

Chiu C.N., Wong S.T., Lee C.L., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Native human zona pellucida glycoproteins: purification and binding properties, Human Reproduction. 2008, 23: 1385.

 

Researcher : Wong YY



List of Research Outputs

 

Ng E.H.Y., So W.Z., Gao J., Wong Y.Y. and Ho P.C., The role of acupuncture in the management of subfertility, Fertility and Sterility. 2008, 90: 1-13.

 

Researcher : Yeung WSB



Project Title:

Functional studies of VCY2 and VCY2 interacting protein (VCY2IP-1)

Investigator(s):

Yeung WSB, Tam PC, Tse JYM, Huang J

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Incentive Award for RGC CERG Fundable But Not Funded Projects

Start Date:

07/2003

 

Abstract:

N/A

 

Project Title:

The mechanisms of action of glycodelin-A on zona pellucida induced acrosome reaction

Investigator(s):

Yeung WSB, Chiu CN, Lee CKF

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

12/2005

 

Abstract:

Glycodelin is a glycoprotein belonging to the lipocalin family. It has 3 reported isoforms; namely amniotic fluid-derived glycodelin-A, seminal plasma-derived glycodelin-S and follicular fluid-derived glycodelin-F (Seppala et al., 2002; Chiu et al., 2003). The isoforms of glycodelin have the same protein core but differ in their glycosylation. Glycodelin-A is the first endogenous glycoprotein found to inhibit spermatozoa-zona pellucida binding (Oehninger et al., 1995). Its absence in the endometrium in the periovulatory period may be related to the presence of a fertilization window (Seppala et al., 1998). Glycodelin-A is produced by the oviduct tissue and is also present in the follicular fluid (Chiu PCN and Yeung WSB, unpublished data). Thus the spermatozoa are likely to come in contact with glycodelin-A in the oviduct before they meet the oocyte. We hypothesize that glycodelin-A has effects on spermatozoa other than its action on spermatozoa-zona pellucida interaction. Indeed, our preliminary data show that glycodelin-A stimulates zona-pellucida-induced acrosome reaction of human spermatozoa, though the molecule does not affect spontaneous acrosome reaction. Acrosome reaction is a critical event in fertilization and is induced by the zona pellucida of oocyte. It allows the spermatozoa to release acrosomal enzymes, and thereby facilitating the penetration of the spermatozoa through the zona pellucida. Our observation suggests that glycodelin-A primes the spermatozoa for this important event of fertilization. The objective of this proposal is to study the intracellular mechanisms in human spermatozoa leading to the priming action of glycodelin-A on zona pellucida-induced acrosome reaction. A priming effect of progesterone on acrosome reaction had been reported in mouse (Roldan et al., 1994) and guinea-pig (Shi et al. 2005) and is regulated by intracellular calcium concentration, phospholipase and/or cAMP/PKA pathway. References Chiu PCN, Koistinen R, Koistinen H, Seppala M, Lee KF, Yeung WSB (2003) Biol Reprod, 69, 365-72. Oehninger S, Coddington CC, Hodgen GD, Seppala M (1995) Fertil Steril, 63, 377-83. Oehninger S, Franken DR, Sayed E, Barroso G, Kolm P (2000) Hum Reprod Update 6, 160-8. Seppala M, Taylor RN, Koistinen H, Koistinen R, Milgrom E (2002) Endocr Rev 23, 401-430.. Seppala M, Koistinen H, Koistinen R, Mandelin E, Oehninger S, Clark GF, Dell A, Morris HR. (1998) Hum Reprod 13 (suppl 3), 262-70. Roldan ER, Murase T, Shi QX (1994) Science, 266(5190), 1578-81. Shi QX, Chen WY, Yuan YY, Mao LZ, Yu SQ, Chen AJ, Ni Y, Roldan ER (2005) J Cell Physiol.[Epub ahead of print].

 

Project Title:

The mechanism of action of a novel glycodelin isoform from cumulus matrix on stimulating spermatozoa-zona pellucida binding

Investigator(s):

Yeung WSB, Chiu CN, Lee CKF

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Competitive Earmarked Research Grants (CERG)

Start Date:

09/2006

 

Abstract:

To determine the effect of glycodelin-C treatment on zona pellucida protein binding; to determine the intracellular signalling pathway of glycodelin-C in human spermatozoa; to study the mechanisms of action of glycodelin-C in increasing spermatozoa-zona binding.

 

Project Title:

Glycodelin-A binds to and protects human spermatozoa from T-lymphocyte attack

Investigator(s):

Yeung WSB, Chiu CN

Department:

Obstetrics & Gynaecology

Source(s) of Funding:

Small Project Funding

Start Date:

09/2006

 

Abstract:

The female reproductive tract is fully capable of cell-mediated and humoral immune responses (Metafora et al., 1989). Spermatozoa express differentiation and histocompatibility antigens on their surface (Martin-Villa et al., 1999) and induces leukocytic reaction in the cervical mucus after insemination leading to massive leukocyte infiltration comprising of polymorphonuclear cells, lymphocytes and macrophages (Thompson et al., 1992). However, this immunologic sensitization of the female to sperm antigens does not lead to immunologic damage of spermatozoa. The mechanism of sperm immunoprotection within the female reproductive tract is not well understood (Barratt and Pockley, 1998). One possible mechanism is the presence of molecules in the female reproductive tract that inhibit the immune response or mask the sperm antigenic determinants recognized by the female's immune system. Glycodelin is a lipocalin glycoprotein with three well-known isoforms, namely glycodelin-A (amniotic fluid isoform), glycodelin-S (seminal plasma isoform) and glycodelin-F (follicular fluid isoform) (Seppala et al., 2002; Yeung et al., 2006). They have the same protein core but with different glycosylation. The most well accepted biological function of glycodelin-A is on immunosuppression. Glycodelin-A inhibits T cell proliferation (Rachmilewitz et al., 1999), induces apoptosis in T cells (Mukhopadhyay et al., 2001) and decreases synthesis of interleukin (IL)-2 and soluble IL-2 receptor (Pockley and Bolton, 1989). Glycodelin-A also renders T cells less sensitive to stimulation (Rachmilewitz et al., 2001) which is mediated by the tyrosine phosphatase receptor CD45 on T cell surfaces (Rachmilewitz et al., 2003). Furthermore, glycodelin-S in the seminal plasma exhibited in vitro immunosuppressive activity, which can be removed by treatment with a monoclonal anti-PP14 antibody-based immunoadsorbent (Bolton et al., 1987). The immunosuppressive activities of glycodelin-F is still unknown. Glycodelin-A, -F and -S binds to the acrosome region of human spermatozoa (Chiu et al., 2003) and is present in the reproductive tract (Seppala et al., 2002; Yeung et al., 2006) through which the spermatozoa must pass before fertilizing the oocyte. We hypothesize that glycodelin-A protects the spermatozoa from lymphocyte attack by binding on the spermatozoa with their carbohydrate moieties. There are 3 objectives in this project. They are 1. To study the effect of glycodelin pretreatment on sperm-mediated stimulation of T-lymphocyte. 2. To determine the mechanism(s) of immunoprotection of glycodelin on spermatozoa 3. To study the role of CD45 in lymphocye on sperm-mediated stimulation of T-lymphocyte References Barratt CL and Pockley AG. (1998) Mol. Hum. Reprod., 4:309-13. Bolton AE, Pockley AG, Clough KJ, Mowles EA, Stoker RJ, Westwood OM and Chapman MG.(1987) Lancet, 1:593-5. Seppala M, Taylor RN, Koistinen H, Koistinen R and Milgrom E. (2002) Endocr Rev., 23:401-30. Martin-Villa JM, Longas J and Arnaiz-Villena A. (1999) Biol Reprod., 61:1381-6. Metafora S, Porta R, Ravagnan G, Spera G, Marchese M, Furgi A, D'Aniello I and Peluso G. (1989) In: Spera G, Gnessi L (eds.), Unexplained Infertility: Basic and Clinical Aspects. New York: Raven Press; 285-296. Mukhopadhyay D, Sundereshan S, Rao C and Karande AA. (2001) J Biol Chem., 276:28268–28273 Pockley AG and Bolton AE. (1989) Clin Exp Immunol., 77:252-6. Rachmilewitz J, Riely GJ and Tykocinski ML. (1999) Cell Immunol., 191:26–33. Rachmilewitz J, Riely GJ, Huang JH, Chen A and Tykocinski ML. (2001) Blood, 98:3727-32. Rachmilewitz J, Borovsky Z, Riely GJ, Miller R and Tykocinski ML. (2003) J Biol Chem., 278:14059-65. Thompson LA, Barratt CLR., Bolton AE and Cooke ID. (1992) Am J Reprod Immunol., 28:85–89. Yeung WS, Lee KF, Koistinen R, Koistinen H, Seppala M, Ho PC and Chiu PC. (2006) Mol Cell Endocrinol., 250:149-56.

 

List of Research Outputs

 

Aflatoonian R., Ward J., Lee C.K.F., Yeung W.S.B., Tsao S.W., Elliott S. and Fazeli A., Sex hormones enhance TLR3 response to its specific ligand in human fallopian tube epithelial cells. P.608, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Chan V.N.Y., Ng E.H.Y., Yeung W.S.B., Yam I.Y.L., Chan T.K. and Ho P.C., Preimplantation genetic diagnosis of thalassaemias, 11th Congress of the International Society of Hematology, Asian-Pacific Division (ISH-APD2007) and the 12th Congress of the Asian-Pacific Bone Marrow Transplantation, Beijing, China, September 21-23. 2007.

 

Cheong A.W.Y., Lee C.Y.L., Liu W., Yeung W.S.B. and Lee C.K.F., Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Cheong W.Y.A., Lee C.Y.L., Liu Y., Yeung W.S.B. and Lee C.K.F., Best poster presentation award HKSEMR 2007- Oviductal microsomal epoxide hydrolase (Ephx1) enhances preimplantation embryo development by suppressing reactiveoxygen species (ROS) production. , The Annual Scientific Meeting of the Hong Kong Society of Endocrinology, Metabolism and Reproduction, 11 November 2007, Hong Kong.. 2007.

 

Chiu C.N., Wong S.T., Lee C.L., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Native human zona pellucida glycoproteins: purification and binding properties, Human Reproduction. 2008, 23: 1385.

 

Chiu C.N., Wong B.S., Lee C.L., Chung M.K., Lam K.K., Pang R.T.K., Lee C.K.F., Sumitro S.B., Gupta S.K. and Yeung W.S.B., Purification of native human zona pellucida glycoproteins from eggs: Binding characteristics to human spermatozoa, hyper-activation, acrosomal exocytosis, and sperm-oocyte interaction. P.74, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Lee C.K.F. and Yeung W.S.B., Cumulus ooporous-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. O.2.05, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K.W., Lee C.L., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Purification and identification of a glycodelin-C interacting protein from human cumulus matrix, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Chung M.K., Chiu C.N., Lam K., Lee C.L., Pang R., Lee C.K.F. and Yeung W.S.B., Study of the interaction of cumulus-associated alpha-2-macroglobulin with glycodelin-C from human cumulus matrix. P. 196, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.K.F., Wong B.P.C., Lai K.Y. and Yeung W.S.B., Cloning and characterization of oviductal demilune cell and parotid protein (Dcpp) gene promoter., The 23rd Annual Meeting of the european Society of Human Reproduction and Embryology. 2007.

 

Lee C.K.F., Wong B.P.C., Lai K.Y. and Yeung W.S.B., Cloning and characterization of oviductal demilune cell and parotid protein (Dcpp) gene promoter, The 23rd Annual Meeting of the european Society of Human Reproduction and Embryology. 2007.

 

Lee C.K.F., Zuo Y., Tam B.Y., Tang A.Y.B. and Yeung W.S.B., Syntaxin and b-actin interact with acrosome-expressing protein VAD1.2/AEP2 in spermatogenesis. P.282, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.K.F., Zuo Y., Tam Y.T., Tang A.Y.B. and Yeung W.S.B., The acrosome-expressing proteins VAD1.3/AEP1 and VAD1.2 interact with syntaxin and b-acting in vitro., The Hong Kong Society of Endocrinology, Metabolism and Reproduction Annual Scientific Meeting. 2007.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., Differential glycosylation regulates the immunosuppressive activities of glycodelins. P3.11, The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Lee C.L., Chiu C.N., Chung M.K., Lam K.K., Chu I.K., Lee C.K.F., Lao T.T.H. and Yeung W.S.B., Impaired immunosuppressive activities of glycodelin-A in pregnant women with gestational diabetes mellitus. P.611, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.L., Chiu C.N., Lam K.W., Chung M.K., Chu I.K., Yeung W.S.B. and Lee C.K.F., The immunosuppressive effect of glycodelin-A from amniotic fluid, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Lee C.Y.L., Liu Y., Ng P.Y., Lee C.K.F., Au C.L., Ng E.H.Y. and Yeung W.S.B., Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation, Human Reproduction. 2008, 23: 894-903.

 

Lee C.Y.L., Chan Y.L., Chow W.N., Ng E.H.Y., Lee C.K.F., Yeung W.S.B. and Ho P.C., Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway., Fertility and Sterility. 2008.

 

Lin S.S.W., Pang R.T.K., Lee C.K.F. and Yeung W.S.B., Microrna expression profile and their regulatory roles in ovarian folliculogenesis , Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Liu Y., Ng E.H.Y., Yeung W.S.B., Ho P.C. and Lee C.K.F., The expression and functional studies of DKK1 and Wnt signaling molecules in human endometrium and embryo implantation. O2.16., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Monkkonen K.S., Aflatoonian R., Lee C.K.F., Yeung W.S.B., Tsao G.S.W., Laitinen J.T. and Fazeli A., Hormonal regulation of G{alpha}i2 and mPR{alpha} in immortalized human oviductal cell line OE-E6/E7., Mol Hum Reprod. 2007, 13: 845-51.

 

Ng E.H.Y., Lau E.Y.L., Yeung W.S.B., Cheung T.M., Tang F.O.S. and Ho P.C., Randomized double-blind comparison of laser zona pellucida thinning and breaching in frozen-thawed embryo transfer at the cleavage stage, Fertility and Sterility. 2008, 89(5): 1147-1153.

 

Ng E.H.Y., Chan C.C.W., Tang F.O.S., Yeung W.S.B. and Ho P.C., The role of endometrial blood flow measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment, European Journal of Obstetrics and Gynecology and Reproductive Biology. 2007, 135: 8-16.

 

Ng P.P.Y., Tang M.H.Y., Lau E.T.K., Ng L.K.L., Ngan E.H.Y., Tam P.C., Yeung W.S.B. and Ho P.C., Chromosome anomalies and Y-microdeletions in subfertile men (Poster), The ACAG-HKSMG International Conference, Hong Kong, 11 June 2008.

 

Ng P.Y., Liu Y., Ng E.H.Y., Ho P.C., Yeung W.S.B. and Lee C.K.F., Differential gene expression of olfactomedin throughout the menstrual cycle is regulated by ovarian hormones., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.508.

 

Pang R.T.K., Liu W., Chiu C.N., Lee C.K.F. and Yeung W.S.B., Microrna regulates notch1 receptor in hela cells, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Sze K.L., Yeung W.S.B. and Fung Y.S., Separation and Determination of Metal Cations in Milk and Dairy Products by CE, Electrophoresis. 2007, 28: 4156-4163.

 

Tam V.C.G., Chiu C.N., Koistinen R., Koistinen M., Seppala M., Ho P.C., Lee C.K.F. and Yeung W.S.B., Glycodelin-C receptor on human spermatozoa., The 23rd Annual Meeting of the European Society of Human Reproduction and Embryology, 1-4 July, Lyon, France.. 2007, P.459.

 

Tse P.K., Lee Y.L., Chow W.N., Luk J.M.C., Lee K.F. and Yeung W.S.B., Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b, Endocrinology. 2008, 149(3): 1268-1276.

 

Wong B.S.T., Chiu C.N., Koistinen R., Koistinen H., Seppala M., Ho P.C., Lee C.K.F. and Yeung W.S.B., Priming effect of glycodelin-A on zona pellucida-induced acrosome reaction in human sperm, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Wu R., Fung Y.S. and Yeung W.S.B., Microfluidic Chip-capillary Electrophoresis for 2-D Separation of Proteins, 7th Asia-Pacific Internationa Symposium on Microscale Separation and Analysis (APCE 2007), Singapore, December 16-19, 2007. Paper 5:49, pp 5:141.

 

Yan Z., Tam Y.T., Cheah K.S.E., Yeung W.S.B. and Lee C.K.F., Functional characterization of VAD 1.3 /AEP 1 Gene in acrosome-formation and fertility, Hong Kong Society of Endocrinology, Metabolism and Reproduction, November 11, 2007, Hong Kong. 2007.

 

Yao Y.Q., Lee C.K.F., Xu J.S., Ho P.C. and Yeung W.S.B., Effect of human oviductal embryotrophic factors on gene expression of mouse preimplantation embryos, Zhonghua Fu Chan Ke Za Zhi (Chinese). 2007, 42(9): 605-607.

 

Zuo Y., Tam Y.T., Yeung W.S.B. and Lee C.K.F., Functional characterization of VAD1.3/AEP1 gene in acrosome-formation and fertility. O2.15., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.

 

Researcher : Yip CT



List of Research Outputs

 

Yip C.T., Chan D.W., Liu V.W.S. and Ngan H.Y.S., Zic2 synergistically enhances Hedgehog signaling pathway in cervical cancer., The 12th Research Postgraduate Symposium 2007, The University of Hong Kong, Hong Kong, 12 Dec. 2007.. 2007.

 

Yip C.T., Chan D.W., Liu V.W.S. and Ngan H.Y.S., Zic2 synergistically enhances Hedgehog signaling pathway in cervical cancer., The 99th Annual Meeting of American Association of Cancer Research, 12-16 April 2008, San Diego, CA, USA.. 2008.

 

Researcher : Yip MW



List of Research Outputs

 

Kwan T.T.C., Chan K.K.L., Yip M.W., Tam K.F., Cheung A.N.Y., Young P.M.C., Lee P.W.H. and Ngan H.Y.S., Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative–quantitative study, Sex Transm Infect. 2008, 84(3): 227-232.

 

Researcher : Zuo Y



List of Research Outputs

 

Lee C.K.F., Zuo Y., Tam B.Y., Tang A.Y.B. and Yeung W.S.B., Syntaxin and b-actin interact with acrosome-expressing protein VAD1.2/AEP2 in spermatogenesis. P.282, The Society for the Study of Reproduction 41st Annual meeting, May 27-30, 2008, Kailua-Kona, Hawaii. 2008.

 

Lee C.K.F., Zuo Y., Tam Y.T., Tang A.Y.B. and Yeung W.S.B., The acrosome-expressing proteins VAD1.3/AEP1 and VAD1.2 interact with syntaxin and b-acting in vitro., The Hong Kong Society of Endocrinology, Metabolism and Reproduction Annual Scientific Meeting. 2007.

 

Zuo Y., Tam Y.T., Yeung W.S.B. and Lee C.K.F., Functional characterization of VAD1.3/AEP1 gene in acrosome-formation and fertility. O2.15., The 12th Research Postgraduate Symposium, The University of Hong Kong, December 12-14, 2007, Hong Kong. 2007.



-- End of Listing --